OriginClear (OCLN) 10-Q 15 May 24 2024 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2024	May 14, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Information [Line Items]
Entity Registrant Name	ORIGINCLEAR, INC.
Entity Central Index Key	0001419793
Entity File Number	333-147980
Entity Tax Identification Number	26-0287664
Entity Incorporation, State or Country Code	NV
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	13575 58th Street North
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Clearwater
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33760
Entity Phone Fax Numbers [Line Items]
City Area Code	(727)
Local Phone Number	440-4603
Entity Listings [Line Items]
Title of 12(b) Security	N/A
No Trading Symbol Flag	true
Security Exchange Name	NONE
Entity Common Stock, Shares Outstanding		1,561,021,044

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
CURRENT ASSETS
Cash	$ 157,351	$ 114,640
Fair value investment in securities	63,292	36,167
Prepaid expenses	11,936
Current assets held-for-sale	1,607,261	2,338,798
TOTAL CURRENT ASSETS	1,839,840	2,489,604
Net property and equipment	136,784	143,366
Net property and equipment held-for-sale	2,689	3,370
NET PROPERTY AND EQUIPMENT	139,473	146,735
OTHER ASSETS
Receivable on sale of asset	66,000	99,000
Fair value investment-securities	3,200	3,200
Trademark	4,467	4,467
Non-current assets held for sale	400,000	400,000
TOTAL OTHER ASSETS	473,667	506,667
TOTAL ASSETS	2,452,980	3,143,007
Current Liabilities
Accounts payable and other payable	659,072	647,483
Accrued expenses	1,839,304	1,774,513
Cumulative preferred stock dividends payable	543,664	523,403
Customer deposit	2,950	2,950
Secured Loans payable	30,646	30,646
Loan payable, SBA	146,557	147,217
Derivative liabilities	20,509,953	7,742,759
Series F 8% Preferred Stock, 60 and 60 shares issued and outstanding, respectively, redeemable value of $50,000 and $60,000 respectively	50,000	60,000
Series G 8% Preferred Stock, 25 and 25 shares issued and outstanding, respectively, redeemable value of $25,000 and $25,000, respectively	25,000	25,000
Series I 8% Preferred Stock, 25 and 25 shares issued and outstanding, respectively, redeemable value of $25,000 and $25,000, respectively	25,000	25,000
Series K 8% Preferred Stock, 307.15 and 407.15 shares issued and outstanding, respectively, redeemable value of $297,150 and $307,150, respectively	297,150	307,150
Convertible secured promissory notes (Note 6)
Convertible promissory notes, net of discount of $0 and $0, respectively (Note 6)	597,945	2,472,944
Current liabilities held-for-sale	22,949,782	20,980,431
Total Current Liabilities	47,677,023	34,739,496
Long Term Liabilities
Convertible promissory notes, net of discount of $0 and $0, respectively	2,019,747	144,747
Total Long Term Liabilities	2,019,747	144,747
Total Liabilities	49,696,770	34,884,243
COMMITMENTS AND CONTINGENCIES (See Note 13)
Convertible preferred stock	7,340,222	7,522,722
SHAREHOLDERS' DEFICIT
Preferred stock, $0.0001 par value, 600,000,000 shares authorized 31,500,000 and 31,500,000 shares of Series D-1 issued and outstanding, respectively	3,150	3,150
Subscription payable for purchase of equipment	100,000	100,000
Common stock, $0.0001 par value, 16,000,000,000 shares authorized 1,478,617,331 and 1,399,782,046 equity shares issued and outstanding, respectively	147,860	139,978
Additional paid in capital - Common stock	82,517,621	81,949,274
Noncontrolling Interest	(2,447,600)	(2,239,493)
Accumulated other comprehensive loss	(132)	(132)
Accumulated deficit	(134,904,911)	(119,216,735)
TOTAL SHAREHOLDERS' DEFICIT	(54,584,012)	(39,263,958)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	2,452,980	3,143,007
Series J Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	210,000	210,000
Series L Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	320,495	320,495
Series M Preferred Stock
Long Term Liabilities
Convertible preferred stock	1,007,500	1,007,500
Series O 8% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	190,000	190,000
Series P Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	30,000	30,000
Series Q 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	410,000	420,000
Series R 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	1,473,000	1,608,000
Series S 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	110,000	120,000
Series U Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	270,000	270,000
Series W 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	846,500	886,500
Series Y Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	$ 2,472,727	$ 2,460,227

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Net of discount (in Dollars)	$ 0	$ 0
Convertible promissory notes, net of discount (in Dollars)	$ 0	$ 0
Preferred stock, shares authorized	600,000,000	600,000,000
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	16,000,000,000	16,000,000,000
Common stock, shares issued	1,478,617,331	1,399,782,046
Common stock, shares outstanding	1,478,617,331	1,399,782,046
Series F 8% Preferred Stock
Preferred Stock, shares issued	60	60
Preferred stock, shares outstanding	60	60
Preferred stock, redeemable value (in Dollars)	$ 50,000	$ 60,000
Series G 8% Preferred Stock
Preferred Stock, shares issued	25	25
Preferred stock, shares outstanding	25	25
Preferred stock, redeemable value (in Dollars)	$ 25,000	$ 25,000
Series I 8% Preferred Stock
Preferred Stock, shares issued	25	25
Preferred stock, shares outstanding	25	25
Preferred stock, redeemable value (in Dollars)	$ 25,000	$ 25,000
Series K 8% Preferred Stock
Preferred Stock, shares issued	307.15	407.15
Preferred stock, shares outstanding	307.15	407.15
Preferred stock, redeemable value (in Dollars)	$ 297,150	$ 307,150
Series J Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 210,000	$ 210,000
Convertible preferred stock, shares issued	210	210
Convertible preferred stock, shares outstanding	210	210
Series L Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 320,495	$ 320,495
Convertible preferred stock, shares issued	320,495	320,495
Convertible preferred stock, shares outstanding	320,495	320,495
Series M Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,007,500	$ 1,007,500
Convertible preferred stock, shares issued	40,300	40,300
Convertible preferred stock, shares outstanding	40,300	40,300
Series O 8% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 190,000	$ 190,000
Convertible preferred stock, shares issued	190	190
Convertible preferred stock, shares outstanding	190	190
Series P Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 30,000	$ 30,000
Convertible preferred stock, shares issued	30	30
Convertible preferred stock, shares outstanding	30	30
Series Q 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 410,000	$ 420,000
Convertible preferred stock, shares issued	410	420
Convertible preferred stock, shares outstanding	410	420
Series R 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,473,000	$ 1,608,000
Convertible preferred stock, shares issued	1,473	1,608
Convertible preferred stock, shares outstanding	1,473	1,608
Series S 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 110,000	$ 120,000
Convertible preferred stock, shares issued	110	120
Convertible preferred stock, shares outstanding	110	120
Series U Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 270,000	$ 270,000
Convertible preferred stock, shares issued	270	270
Convertible preferred stock, shares outstanding	270	270
Series W 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 846,500	$ 886,500
Convertible preferred stock, shares issued	846.5	886.5
Convertible preferred stock, shares outstanding	846.5	886.5
Series Y Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 2,472,727	$ 2,460,227
Convertible preferred stock, shares issued	24.7	24.6
Convertible preferred stock, shares outstanding	24.7	24.6
Series D-1 Preferred Stock
Preferred Stock, shares issued	31,500,000	31,500,000
Preferred stock, shares outstanding	31,500,000	31,500,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Sales	$ 6,573	$ 6,573
Cost of Goods Sold
Gross Profit	6,573	6,573
Operating Expenses
Selling and marketing expenses	526,640	796,619
General and administrative expenses	893,300	905,916
Depreciation and amortization expense	6,582	6,690
Total Operating Expenses	1,426,522	1,709,225
Loss from Operations	(1,419,949)	(1,702,652)
OTHER INCOME (EXPENSE)
Impairment of receivable from SPAC		(50,000)
Unrealized gain (loss) on investment securities	27,125	(4,521)
Gain (Loss) on redemption of common stock	687,678	1,802,443
Gain (Loss) on net change in derivative liability and conversion of debt	(12,767,194)	3,875,377
Interest and dividend expense	(186,982)	(223,440)
TOTAL OTHER (EXPENSE) INCOME	(12,239,373)	5,399,859
Net income (loss) from continued operations	(13,659,322)	3,697,207
Net loss from assets held-for-sale	(2,236,961)	(4,188,741)
NET LOSS	$ (15,896,283)	$ (491,534)
Basic earnings per share from continuing operations (in Dollars per share)	$ 0	$ 0
Basic (loss) earnings per share from assets held-for-sale (in Dollars per share)	0	0
BASIC (in Dollars per share)	$ (0.01)	$ 0
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC (in Shares)	1,443,544,402	1,062,100,064

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Diluted earnings per share from continuing operations	$ 0	$ 0
Diluted (loss) earnings per share from assets held-for-sale	0	0
DILUTED	$ (0.01)	$ 0
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, DILUTED (in Shares)	1,443,544,402	1,062,100,064

Condenced Consolidated Statemen

Condenced Consolidated Statements of Shareholders' Deficit - USD ($)	Preferred stock	Mezzanine Equity	Common stock	Additional Paid-in- Capital	Subscription Payable	Accumulated Other Comprehensive loss	Noncontrolling Interest	Accumulated Deficit	Total
Balance at Dec. 31, 2022	$ 3,150	$ 10,866,772	$ 101,337	$ 82,745,503	$ 100,000	$ (132)		$ (108,966,645)	$ (26,016,787)
Balance (in Shares) at Dec. 31, 2022	32,502,475		1,013,369,185
Common stock issued for cash per equity financing agreement			$ 1,865	128,719					130,584
Common stock issued for cash per equity financing agreement (in Shares)			18,645,028
Common stock issued at fair value for services			$ 2,371	250,839					253,210
Common stock issued at fair value for services (in Shares)			23,716,123
Common stock issued for conversion of Series O Preferred stock		(40,000)	$ 772	39,228					40,000
Common stock issued for conversion of Series O Preferred stock (in Shares)			7,722,008
Common stock issued for conversion of Series Q Preferred stock		(25,000)	$ 421	24,579					25,000
Common stock issued for conversion of Series Q Preferred stock (in Shares)			4,208,756
Common stock issued for conversion of Series R Preferred stock		(365,000)	$ 7,065	357,935					365,000
Common stock issued for conversion of Series R Preferred stock (in Shares)			70,652,445
Common stock issued for conversion of Series S Preferred stock		(25,000)	$ 421	24,579					25,000
Common stock issued for conversion of Series S Preferred stock (in Shares)			4,208,756
Common stock issued for conversion of Series Y Preferred stock		(420,000)	$ 6,366	413,634					420,000
Common stock issued for conversion of Series Y Preferred stock (in Shares)			63,656,525
Common stock issued for Series O Preferred stock dividends			$ 24	(24)
Common stock issued for Series O Preferred stock dividends (in Shares)			238,003
Common stock issued for conversion settlement			$ 8,584	(8,584)
Common stock issued for conversion settlement (in Shares)			85,836,889
Common stock issued for alternative vesting			$ 883	91,841					92,724
Common stock issued for alternative vesting (in Shares)			8,830,859
Issuance of Series A Preferred stock granted to Series Y investors
Issuance of Series A Preferred stock granted to Series Y investors (in Shares)	202
Issuance of Series Y Preferred stock through a private placement		345,000
Exchange of Series R Preferred Stock for WODI secured convertible note		(100,000)
Exchange of Series X Preferred Stock for WODI secured convertible note		(250,000)
Redemption of common stock for note purchase agreement			$ (18,214)	(1,784,229)					(1,802,443)
Redemption of common stock for note purchase agreement (in Shares)			(182,145,203)
Net Loss								(491,534)	(491,534)
Balance at Mar. 31, 2023	$ 3,150	9,986,772	$ 111,895	82,284,020	100,000	(132)		(109,458,179)	(26,959,246)
Balance (in Shares) at Mar. 31, 2023	32,502,677		1,118,939,374
Balance at Dec. 31, 2023	$ 3,150	7,522,722	$ 139,978	81,949,274	100,000	(132)	(2,239,493)	(119,216,735)	(39,263,958)
Balance (in Shares) at Dec. 31, 2023	31,501,000		1,399,782,046
Common stock issued at fair value for services			$ 2,070	211,011					213,081
Common stock issued at fair value for services (in Shares)			20,698,356
Common stock issued for conversion of Series Q Preferred stock		(20,000)	$ 458	19,542					20,000
Common stock issued for conversion of Series Q Preferred stock (in Shares)			4,576,458
Common stock issued for conversion of Series R Preferred stock		(135,000)	$ 3,050	131,950					135,000
Common stock issued for conversion of Series R Preferred stock (in Shares)			30,496,772
Common stock issued for conversion of Series S Preferred stock		(10,000)	$ 227	9,773					10,000
Common stock issued for conversion of Series S Preferred stock (in Shares)			2,272,728
Common stock issued for conversion of Series W Preferred stock		(50,000)	$ 1,166	48,835					50,001
Common stock issued for conversion of Series W Preferred stock (in Shares)			11,655,012
Common stock issued for conversion of Series Y Preferred stock		(240,000)	$ 5,205	234,795					240,000
Common stock issued for conversion of Series Y Preferred stock (in Shares)			52,047,138
Common stock issued for Series O Preferred stock dividends			$ 17	(17)
Common stock issued for Series O Preferred stock dividends (in Shares)			172,730
Common stock issued for conversion settlement			$ 1,933	(1,933)
Common stock issued for conversion settlement (in Shares)			19,330,459
Rounding			$ (3)	2					1
Shares redeemed/cancelled for Note Purchase Agreement			$ (8,335)	(679,343)					(687,678)
Shares redeemed/cancelled for Note Purchase Agreement (in Shares)			(83,352,197)
Common stock issued for alternative vesting			$ 2,094	167,502					169,596
Common stock issued for alternative vesting (in Shares)			20,937,829
Issuance of Series Y Preferred stock through a private placement		252,500
Exchange of Series F preferred stock for Series Q preferred stock		10,000
Exchange of Series K preferred stock for Series W preferred stock		10,000
Issuance of warrants				426,230					426,230
Net Loss							(208,107)	(15,688,176)	(15,896,283)
Balance at Mar. 31, 2024	$ 3,150	$ 7,340,222	$ 147,860	$ 82,517,622	$ 100,000	$ (132)	$ (2,447,600)	$ (134,904,911)	$ (54,584,010)
Balance (in Shares) at Mar. 31, 2024	31,501,000		1,478,617,331

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (loss) from continuing operations	$ (13,659,322)	$ 3,697,207
Net loss related to assets held-for-sale	(2,236,961)	(4,188,741)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization	7,264	7,829
Common and preferred stock issued for services	213,081	253,210
Change in fair value of derivative liability	12,767,194	(3,875,377)
Converted value of secured promissory notes		2,505,339
Stock based compensation expense	169,596	92,724
Net unrealized (gain) loss on fair value of securities	(27,125)	4,521
Impairment of receivable from SPAC	590,000	1,657,920
Conversion and settlement value loss on WODI	692,000
Gain on redemption of common stock	(687,678)	(1,802,443)
Change in Assets (Increase) Decrease in:
Contracts receivable	758,374	346,797
Contract asset	101,791	47,700
Prepaid expenses and other assets	(11,936)	13,628
Change in Liabilities Increase (Decrease) in:
Accounts payable	(341,187)	(921,795)
Accrued expenses	487,156	177,439
Contract liabilities	451,997	(15,523)
NET CASH USED IN OPERATING ACTIVITIES	(725,756)	(1,906,841)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of SPAC notes payable	(590,000)	(1,657,920)
Payments received on long term asset	33,000
Purchase of fixed assets	(4,500)	(4,500)
NET CASH USED IN INVESTING ACTIVITIES	(561,500)	(1,662,420)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on loan payable, SBA	(660)	(633)
Proceeds from Line of credit		200,000
Payments on Line of credit	(89,040)
Payments on loans, merchant cash advance	(110,695)
Equity financing purchase agreement		130,584
Net payments on cumulative preferred stock dividends and distributions	20,261	3,210
Proceeds from convertible secured promissory notes	960,000	2,532,000
Proceeds from issuance of warrants	426,230
Net proceeds for issuance of preferred stock for cash - mezzanine classification	252,500	345,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,458,596	3,210,161
NET (DECREASE) INCREASE IN CASH	171,340	(451,824)
CASH BEGINNING OF PERIOD	488,830	1,354,814
CASH END OF PERIOD	660,170	902,990
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest and dividends paid		255,983
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Issuance of Series O dividends	17	24
Preferred stock converted to common stock - mezzanine	455,000	875,000
Exchange of Series R preferred stock for WODI secured convertible note		100,000
Exchange of Series X preferred stock for WODI secured convertible note		250,000
Common stock issued as settlement	$ 1,933	$ 8,584

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2024
Basis of Presentation [Abstract]
BASIS OF PRESENTATION	1. BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements of OriginClear, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2023. OriginClear was founded as OriginOil® in 2007 and began trading on the OTC in 2008. In 2015, it was renamed as OriginClear® to reflect its new mission to develop breakthrough businesses in the industrial water sector. Today, OriginClear structures itself as the Clean Water Innovation Hub™ and intends to use its well-developed retail investor development capabilities to help bring potentially disruptive companies to market. For the foreseeable future, however, OriginClear intends to devote its entire capabilities to the success of its subsidiary, Water On Demand, Inc. (WODI). In 2023, OriginClear combined three of its operating divisions into WODI in anticipation of a merger of such subsidiary with Fortune Rise Acquisition Corp (“FRLA”) a Special Purpose Acquisition Company. The definitive merger agreement between WODI and FRLA was announced on October 24, 2023: https://www.originclear.com/company-news/originclears-water-on-demand-and-fortune-rise-acquisition-corporation-announce-business-combination-to-create-nasdaq-listed-company. WODI is now composed of three operating units, Modular Water Systems (“MWS”), Progressive Water Treatment (“PWT”), and Water on Demand (“WOD”), the last being a development stage business. ● PWT is responsible for a significant percentage of the Company’s revenue, specializing in engineered water treatment solutions and custom treatment systems. ● MWS houses a worldwide, exclusive master license to the intellectual property of Daniel M. Early, consisting of five patents and related intellectual property, know-how and trade secrets (“Early IP”). In April 2023, OriginClear commissioned a valuation of the Early IP. MWS, features products differentiated by the Early IP and complemented with additional knowhow and trade secrets. ● WOD is an incubation of the Company which intends to offer private businesses water self-sustainability as a service - the ability to pay for water treatment and purification services on a per-gallon basis. This is commonly known as Design-Build-Own-Operate (“DBOO”). Going Concern The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2023 expressed substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, achieving a level of profitable operations and receiving additional cash infusions. During the three months ended March 31, 2024, the Company obtained funds from the issuance of convertible note agreements and from sale of its preferred stock. Management believes this funding will continue from its’ current investors and from new investors. The Company generated revenue of $6,573 and its operating divisions have standing purchase orders and open invoices with customers, which will provide funds for operations. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case of equity financing.

Summary of Significant Accounti

Summary of Significant Accounting Polices	3 Months Ended
	Mar. 31, 2024
Summary of Significant Accounting Polices [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its subsidiaries Water On Demand, Inc. (‘WODI’), (which consists of operating divisions Progressive Water Treatment, Modular Water Systems and Water On Demand), Water On Demand #1, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Net Earnings (Loss) per Share Calculations Basic loss per share calculation is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted earnings per share were not the same as the basic loss per share for the three months ended March 31, 2024 and 2023, respectively, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. For the Three Months Ended 2024 2023 Loss to common shareholders (Numerator) – continuing operations $ (13,659,322 ) $ 3,789,931 Loss to common shareholders (Numerator) – related to assets held-for sale (2,236,961 ) (4,188,741 ) Basic and diluted weighted average number of common shares outstanding (Denominator) 1,443,544,402 1,062,100,064 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive. Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs. Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was $368,917 and $379,335 as of March 31, 2024 and December 31, 2023, respectively. The net contract receivable balance was $751,130 and $1,509,504 at March 31, 2024 and December 31, 2023, respectively. Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at March 31, 2024 and 2023, respectively, and determined there was no impairment of indefinite lived intangibles and goodwill. Prepaid Expenses The Company records expenditures that have been paid in advance as prepaid expenses. The prepaid expenses are initially recorded as assets, because they have future economic benefits, and are expensed at the time the benefits are realized. The prepaid expenses balance was $11,936 and $0 at March 31, 2024 and December 31, 2023, respectively. Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years 3/31/2024 12/31/23 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 66,493 66,493 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 607,012 607,012 Less accumulated depreciation (467,539 ) (460,277 ) Net Property and Equipment $ 139,473 $ 146,735 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that the facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the three months ended March 31, 2024 and 2023, was $6,582 and $6,690, respectively. Other Assets Long Term Asset Held for Sale On March 1, 2021, the Company issued an aggregate of 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per terms of a Securities Purchase Agreement (the “SPA”). Per the SPA, the Company agreed to sell to Purchaser, and Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share per terms of the SPA, which were exercisable at any time in whole or in part. The purchaser and the Company agreed that in lieu of the purchase price for the Series T, the Purchaser transferred to the Company real property, with an aggregate value agreed to be $630,000 based on an appraisal from an international independent company at that time. The real property consisted of residential real estate in Buenos Aires Argentina valued at $580,000, and eight undeveloped lots valued at $50,000 in Terralta private neighborhood development. The real property exchanged for 630 shares of Series T was recorded at $630,000 and reflected on the balance sheet as a long term asset for sale at that time. The real property was listed for sale beginning in July 2021. However, based on indicators of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the asset for sale from $630,000 to $514,000 and recorded an impairment of $116,000 in the consolidated financial statements During the period ended December 31, 2022, after evaluating several offers, the Company considered an offer for $400,000, which was $114,000 below the previously adjusted value and was indicative of the real estate market conditions in Buenos Aires Argentina. Based on that indicator of impairment, during the year ended December 31, 2022, the Company further adjusted the previous value of the asset for sale from $514,000 to $400,000 on the balance sheet and recorded an impairment of $114,000 in the consolidated financial statements. All Series T preferred stock was converted and the warrants associated with the Series T expired during the period ended December 31, 2022. In January 2023, the Company accepted the offer and on April 8, 2023, a deed was executed for the sale of the property for $400,000. The agreed upon payment terms were; $235,000 initial payment and the remaining $165,000 to be paid over fifteen monthly installments of $11,000 each. The initial payment was received by SMS Argentina (“SMS”), an accounting and consulting firm that was appointed by the Company as the Power of Attorney for the property. From the proceeds, SMS remitted taxes due on the transaction to the Federal Administration of Public Income (“AFIP”), which administers taxation in Argentina. On June 21, 2023, the Company received a payment of $164,935, net of all taxes assessed by AFIP and other closing fees associated with the sale of the property totaling $65,493 and recorded a receivable of $169,572 for the remaining amount on the consolidated financial statements as of June 30, 2023. Between July 1, 2023 through March 31, 2024, the Company received additional payments totaling $103,572. As of March 31, 2024, the balance of the receivable was $66,000 which is reflected on the consolidated financial statements. Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants vest immediately and the total stock-based compensation charge is recorded in the period of the measurement date. Accounting for Derivatives The Company evaluates all its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not to recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2024, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of March 31, 2024. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, March 31, 2024 $ 66,492 $ 66,492 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, March 31, 2024 $ 20,509,953 $ - $ - $ 20,509,953 The derivative liabilities consist of $20,052,649 for convertible notes outstanding and $457,304 for warrants outstanding for an aggregate of $20,509,953. The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of December 31, 2023 $ 7,742,759 Net loss on conversion of debt and change in derivative liabilities 12,767,194 Balance as of March 31, 2024 $ 20,509,953 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 3/31/2023 Risk free interest rate 4.53% – 4.96% Stock volatility factor 141% – 219% Weighted average expected option life 6 mos - 5 yrs Expected dividend yield None Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated. Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income. Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered. Reclassification Certain amounts in the prior period financial statements have been reclassified to conform to the presentation used in the current financial statements for comparative purpose. There was no material effect on the Company’s previously issued financial statements. Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers. Recently Issued Accounting Pronouncements Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Wodi Assets and Liabilities Hel

Wodi Assets and Liabilities Held-for-Sale – Discontinuing Operations	3 Months Ended
	Mar. 31, 2024
Wodi Assets and Liabilities Held-for-Sale – Discontinuing Operations [Abstract]
WODI ASSETS AND LIABILITIES HELD-FOR-SALE – DISCONTINUING OPERATIONS	3. WODI ASSETS AND LIABILITIES HELD-FOR-SALE – DISCONTINUING OPERATIONS On September 21, 2023, WODI entered into a merger agreement with PWT whereby WODI was merged with PWT. The merger of these entities was completed to create better enterprise value for a potential merger opportunity with FRLA. In connection with the merger with WODI, PWT changed its name to Water on Demand, Inc. On September 28, 2023, the Letter of Intent (“LOI”) executed on January 5, 2023 with WODI was amended to designate PWT as the new target of the acquisition. Under the amended LOI, FRLA proposed to acquire all the outstanding securities of the new combined WODI/PWT entity, based on certain material financial and business terms and conditions being met. The LOI is not binding on the parties and is intended solely to guide good-faith negotiations toward definitive agreements. On October 24, 2023, FRLA and WODI entered into a definitive business combination agreement (the “BCA”). The transaction represents a pro forma equity valuation of approximately $72 million of the Combined Company, assuming no further redemptions of FRLA public shares by FRLA’s public shareholders. On October 25, 2023, at the Special Meeting, FRLA shareholders approved a proposal to extend the period of time FRLA has to consummate its initial business combination by an additional one year from November 5, 2023 to November 5, 2024, by up to twelve one-month extensions, subject to certain conditions. On February 14, 2024, the Company and Fortune Rise Acquisition Corporation (Nasdaq: FRLA), filed a registration statement on Form S-4 with the SEC which includes a preliminary proxy statement and prospectus in connection with the proposed business combination with WODI. In accordance with ASC 205-20, a disposal of a component or a group of components should be reported in discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when a component of or group of components meets the initial criteria for classification of held for sale to be classified as held for sale. Per the initial criteria for classification of held for sale, a component or a group of components, or a business or nonprofit activity (the entity to be sold), should be classified as held for sale in the period in which all of the following criteria are met: ● Management, having the authority to approve the action, commits to a plan to sell the entity to be sold. ● The entity to be sold is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such entities to be sold. ● An active program to locate a buyer or buyers and other actions required to complete the plan to sell the entity to be sold have been initiated. ● The sale of the entity to be sold is probable (the future event or events are likely to occur), and transfer of the entity to be sold is expected to qualify for recognition as a completed sale, within one year, unless events or circumstances beyond an entity’s control extend the period required to complete the sale as discussed below. ● The entity to be sold is being actively marketed for sale at a price that is reasonable in relation to its current fair value. ● Actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. Since the proposed business combination of WODI with FRLA, meets all the initial criteria for classification of held for sale, the assets, liabilities and operating results of WODI have been classified as held for sale in the period ending March 31, 2024 and financial statements of the prior year ending in December 31, 2023 have been adjusted to reflect comparable as follows: Assets and Liabilities Held-For-Sale March 31, December 31, 2024 2023 CURRENT ASSETS Cash $ 502,820 $ 374,192 Contracts receivable, net allowance of $368,917 and $379,335, respectively (See Note 2) 751,130 1,509,504 Contract assets (See Note 7) 353,311 455,102 Total Current Assets Held-For-Sale 1,607,261 2,338,798 NET PROPERTY AND EQUIPMENT HELD-FOR-SALE 2,689 3,370 NON-CURRENT ASSETS HELD-FOR SALE SPAC Class B common shares purchase cost (See Note 10) 400,000 400,000 CURRENT LIABILITIES HELD-FOR-SALE Accounts payable and other payable $ 982,435 $ 1,335,211 Accrued expenses 1,521,023 1,103,159 Contract liabilities (See Note 7) 1,798,364 1,346,366 Tax liability 83(b) 13,600 13,600 Customer deposit 143,503 143,503 Warranty reserve 20,000 20,000 Line of credit (See Note 11) 89,768 178,808 Secured Loans payable - 110,695 Convertible secured promissory notes (See Note 6) 18,381,089 16,729,089 Total Current Liabilities Held-For-Sale $ 22,949,782 $ 20,980,431 Net Loss from Assets Held-For-Sale Three Months Ended March 31, March 31, 2024 2023 Sales $ 936,864 $ 1,999,821 Cost of Goods Sold 1,055,940 1,875,319 Gross Profit (119,076 ) 124,502 Operating Expenses Selling and marketing expenses 62,324 17,603 General and administrative expenses 315,226 275,578 Depreciation and amortization expense 682 1,139 Total Operating Expenses 378,232 294,320 Loss from Operations (497,308 ) (169,818 ) OTHER INCOME (EXPENSE) Other income 809 142,797 Impairment of receivable from SPAC (590,000 ) (1,607,920 ) Conversion and settlement value added to note purchase agreements (See Note 6) (692,000 ) (2,505,339 ) Interest expense (458,462 ) (48,461 ) TOTAL OTHER (EXPENSE) INCOME (1,739,653 ) (4,018,923 ) NET LOSS FROM ASSETS-HELD-FOR-SALE $ (2,236,961 ) $ (4,188,741 )

Capital Stock

Capital Stock	3 Months Ended
	Mar. 31, 2024
Capital Stock [Abstract]
CAPITAL STOCK	4. CAPITAL STOCK OriginClear, Inc. Preferred Stock Series C On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange for his continued employment with the Company. The holder of Series C preferred stock is not entitled to receive dividends, is not entitled to any liquidation preference and shares of Series C preferred stock does not have any conversion rights. The Series C Preferred Stock entitles the holder to 51% of the total voting power of our stockholders. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares. As of March 31, 2024, there were 1,000 shares of Series C preferred stock outstanding held by Mr. Eckelberry. Series D-1 On April 13, 2018, the Company designated 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock are not entitled to dividends and do not have a liquidation preference. Each share of Series D-1 preferred stock is convertible into 0.0005 of one share of common stock. The Series D-1 preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock, which amount may be increased to 9.99% at the holders discretion upon 61 days’ written notice. As of March 31, 2024, there were 31,500,000 shares of Series D-1 preferred stock issued and outstanding. Series F On August 14, 2018, the Company designated 6,000 shares as Series F preferred stock. The shares of Series F preferred stock have a liquidation preference equal to the stated value of $1,000 per share plus any accrued but unpaid dividends. The Series F preferred stock is not convertible into common stock. The holders of outstanding shares of Series F preferred stock are entitled to quarterly dividends at the annual rate of 8% of the stated value, in preference to any dividends on the common stock. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company was required to redeem all outstanding shares of Series F preferred stock on September 1, 2020. During the three months ended March , 2024, the Company exchanged an aggregate of shares of Series F preferred stock for shares of Series Q preferred stock. The shares were exchanged within the terms of the agreement and no gain or loss was recognized. the Company had 50 outstanding shares of Series F preferred stock, which the Company was required to, and failed to redeem on September 1, 2020, and remains in default for an aggregate redemption price (equal to the stated value) of $50,000 Series G On January 16, 2019, the Company designated 6,000 shares as Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The Series G preferred stock does not have voting rights, except as required by law and is not convertible into common stock. The Company may, in its sole discretion, at any time while the Series G preferred stock is outstanding, redeem all or any portion of the outstanding Series G preferred stock at a price equal to the stated value plus any accrued but unpaid dividends. The Company was required to redeem such shares of Series G preferred stock on April 30, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser received shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. As of March 31, 2024, there were 25 shares of Series G preferred stock issued and outstanding, which the Company was required to, and failed to redeem on April 30, 2021, for an aggregate redemption price (equal to the stated value) of $25,000. Series I On April 3, 2019, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I is not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company has the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series I between May 2, 2021 and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. As of , there were 25 shares of Series I preferred stock issued and outstanding which the Company was required to, and failed to redeem by June 10, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $25,000 Series J On April 3, 2019, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain make-good shares for certain prior investors. As of , there were 210 shares of Series J preferred stock issued and outstanding Series K On June 3, 2019, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K is not entitled to any voting rights except as may be required by applicable law and is not convertible into common stock. The Company has the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company was required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series K between August 5, 2021 and April 24, 2022, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the three months ended March , 2024, the Company exchanged an aggregate of shares of Series K preferred stock for shares of Series W preferred stock. The shares were exchanged within the terms of the agreement and no gain or loss was recognized. As of , there were 297 shares of Series K preferred stock issued and outstanding which the Company was required to, and failed to redeem by April 24, 2022, and was and remains in default for an aggregate redemption price (equal to the stated value) of $297,150 Series L On June 3, 2019, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into shares of the Company’s common stock pursuant to the Series L COD, which includes certain make-good shares for certain prior investors. As of there were 321 shares of Series L preferred stock issued and outstanding. Series M Pursuant to the Amended and Restated Certificate of Designation of Series M Preferred Stock filed with the Secretary of State of Nevada on July 1, 2020, the Company designated 800,000 shares of its preferred stock as Series M Preferred Stock. Each share of Series M Preferred Stock has a stated value of $25. The Series M Preferred Stock is not convertible into common stock. The holders of outstanding shares of Series M Preferred Stock are entitled to receive dividends, at the annual rate of 10%, payable monthly, payable in preference and priority to any payment of any dividend on the common stock. The Series M Preferred Stock is entitled to a liquidation preference in an amount equal to $25 per share plus any declared but unpaid dividends, before any payments to holders of common stock. The Series M Preferred Stock have no pre-emptive or subscription rights, and there are no sinking fund provisions applicable to the Series M Preferred Stock. The Series M Preferred Stock does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the Certificate of Designation of Series M Preferred Stock (see ITEM 15. Exhibit 3.29). To the extent it may lawfully do so, the Company may, in its sole discretion, at any time when there are outstanding shares of Series M Preferred Stock, redeem any or all of the then outstanding shares of Series M Preferred Stock at a redemption price of $37.50 per share (150% of the stated value) plus any accrued but unpaid dividends. As of March 31, 2024, there were 40,300 shares of Series M preferred stock issued and outstanding. Series O On April 27, 2020, the Company designated 2,000 shares of preferred stock as Series O preferred stock. The Series O preferred stock has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O preferred stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series O preferred stock has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series O preferred stock. The Series O preferred stock does not have voting rights except as required by law. The Series O preferred stock is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O preferred stock being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series O preferred stock at any time while the Series O preferred stock are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the three months ended the Company issued an aggregate of 172,730 shares of common stock in prorated 4% annualized dividends which were recorded as interest expense. The shares were issued within the terms of the agreement and no gain or loss was recognized. , there were 190 shares of Series O preferred stock issued and outstanding Series P On April 27, 2020, the Company designated 500 shares of preferred stock as Series P preferred stock. The Series P preferred stock has a stated value of $1,000 per share and entitles holders to receive dividends on an as-converted basis with the Company’s common stock. The Series P preferred stock is convertible into stock of the Company pursuant to the Series P COD, which includes certain make-good shares for certain prior investors, and provided that, the Series P preferred stock may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Series P preferred stock entitles the holders to a payment on an as-converted and pari-passu basis with the common stock upon any liquidation. The Series P preferred stock has no preemptive or subscription rights, and there is no sinking fund or redemption provisions applicable to the Series P preferred stock. The Series P preferred stock votes on an as-converted basis with the common stock, subject to the beneficial ownership limitation. As of , there were 30 shares of Series P preferred stock issued and outstanding. Series Q On August 21, 2020, the Company designated 2,000 shares of preferred stock as Series Q Preferred Stock. The Series Q Preferred Stock has a stated value of $1,000 per share and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series Q Preferred Stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series Q Preferred Stock has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series Q Preferred Stock. The Series Q Preferred Stock does not have voting rights except as required by law. The Series Q Preferred Stock is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series Q Preferred Stock being converted by the conversion price, provided that, the Series Q may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series Q Preferred Stock at any time while the Series Q Preferred Stock are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the three months ended , the Company issued an aggregate of 4,576,458 shares of common stock upon conversion of 20 shares of Series Q preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of , there were 410 shares of Series Q preferred stock issued and outstanding Series R On November 16, 2020, the Company designated 5,000 shares of preferred stock as Series R. The Series R has a stated value of $1,000 per share and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series R holders are not entitled to any voting rights except as may be required by applicable law. The Series R is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series R being converted by the conversion price; certain prior investors will also be entitled to certain make-good shares; provided that, the Series R may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series R at any time while the Series R are outstanding at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid cash dividends, or, if paid in shares of common stock, in an amount of shares determined by dividing the stated value being redeemed by the conversion price. During the three months ended , the Company issued an aggregate of 30,496,772 shares of common stock upon conversion of 135 shares of Series R preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of , there were 1,473 shares of Series R preferred stock issued and outstanding Series S On February 5, 2021, the Company designated 430 shares of preferred stock as Series S. The Series S has a stated value of $1,000 per share and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series S holders are not entitled to any voting rights except as may be required by applicable law. The Series S is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series S being converted by the conversion price, provided that, the Series S may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series S at any time while the Series S are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the three months ended , the Company issued an aggregate of 2,272,728 shares of common stock upon conversion of 10 shares of Series S preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. Series U On May 26, 2021, the Company designated 5,000 shares of preferred stock as Series U. The Series U has a stated value of $1,000 per share. The Series U holders are not entitled to any dividends and do not have any voting rights except as may be required by applicable law. The Series U is convertible into common stock of the Company in an amount determined by dividing 150% of the stated value of the Series U being converted by the conversion price; certain prior investors will also be entitled to certain make-good shares; provided that, the Series U may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the lesser of $0.20 or the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series U at any time at a redemption price equal to, if paid in cash, the stated value, or, if paid in shares of common stock, in an amount of shares determined by dividing 200% of the stated value being redeemed by the conversion price then in effect, and adding any applicable make-good shares. As of March 31, 2024, there were 270 shares of Series U preferred stock along with 1,561,500 warrants with a fair value of $0 (with exercise price of $1) issued and outstanding. These warrants associated with Series U were valued using the Black Scholes model (See Note 5) Series W On April 28, 2021, the Company designated 3,390 shares of preferred stock as Series W. The Series W has a stated value of $1,000 per share, and Series W holders are entitled to cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly. The Series W holders are not entitled to any voting rights except as may be required by applicable law. The Series W is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series W being converted by the conversion price; provided that, the Series W may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series W at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the three months ended , the Company issued an aggregate of 11,655,012 shares of common stock upon conversion of 50 shares of Series W preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of March 31, 2024, there were 847 shares of Series W preferred stock issued and outstanding Series Y On December 6, 2021, the Company designated 3,000 shares of preferred stock as Series Y. The Series Y has an original issue price of $100,000 per share, and holders are entitled to receive, on a pro rata and pari passu basis, annual distribution of up to 25% of annual net profits of newly established, wholly-owned, Water On Demand subsidiaries, designated by each holder, paid within 3 months of subsidiary’s accounting year-end. The Series Y holders are not entitled to any voting rights except as may be required by applicable law. The Series Y is convertible into common stock of the Company pursuant to the Series Y COD, provided that, the Series Y may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company has the right (but no obligation) to redeem the Series Y at any time at a redemption price equal to, if paid in cash, the original issue price plus any accrued but unpaid distributions of 25% of the subsidiary’s annual net profits. In addition, the Series Y holders received shares of Series A preferred stock in the Company’s subsidiary Water On Demand, Inc or warrants to purchase common shares in Water On Demand, Inc. During the three months ended March 31, 2024, the Company received aggregate funding in the amount of $252,500 through the sale of Series Y preferred stock The shares were issued within the terms of the agreement and no gain or loss was recognized. Series Z On February 11, 2022, the Company designated 25 shares of preferred stock as Series Z. The Series Z had an original issue price of $10,000 per share. The Series Z holders were not entitled to dividends or any voting rights. The Series Z was convertible into common stock of the Company pursuant to the Series Z COD, provided that, the Series Z may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which amount may be increased up to 9.99% upon 61 days’ written notice). On February 18, 2022, the Company issued and sold to an accredited investor an aggregate of shares of Series Z preferred stock and issued an aggregate of warrants. The 25 shares of Series Z were converted to Company’s common stock during the year ended As of March 31 , there were 2,500,000 warrants with a fair value of $16,183 (with an exercise price of $0.10) and no shares of Series Z preferred stock issued and outstanding. . As of March 31, 2024, the Company accrued aggregate dividends in the amount of $543,664 for all series of preferred stock. During the three months ended March 31, 2024, the Company redeemed an aggregate of 83,352,197 shares of common stock at a price of $0.01 per share and recognized a gain of $687,678 in the consolidated statements of operations relating to settlement and conversion agreements The Series J, Series L, Series M, Series O, Series P, Series Q, Series R, Series S, Series U, Series W, Series Y, and Series Z preferred stock are accounted for outside of permanent equity due to the terms of conversion at a market component or stated value of the preferred stock. Water On Demand, Inc. (“WODI”) Preferred Stock On April 22, 2022, WODI authorized 50,000,000 shares of preferred stock at $0.0001 par value per share. Due to WODI’s merger with PWT on September 21, 2023 ( See Note 10) As of OriginClear, Inc. Common Stock Three Months Ended March 31, 2024 The Company issued 20,698,356 shares of common stock for services at fair value of $213,081, at share prices ranging from $0.0065 - $0.011. The Company issued 172,730 shares of common stock for Series O preferred stock dividends payable. The Company issued 20,937,829 shares of common stock for alternate vesting at a fair value of $169,596. The Company issued 101,048,108 shares of common stock upon conversion of $455,000 of preferred stock. The Company redeemed 83,352,197 shares of common stock at a market price of $0.01 per share with a gain in the amount of $687,678. Three Months Ended March 31, 2023 The Company issued 18,645,028 shares of common stock for cash, through an equity financing agreement for a total aggregate of $130,584 based upon conversion prices ranging from $0.0064 to $0.00816. The Company issued 23,716,123 shares of common stock for services at fair value of $253,210, at share prices ranging from $0.0051 - $0.0135. The Company issued 238,003 shares of common stock for Series O preferred stock dividends payable. The Company issued 85,836,889 shares of common stock for settlement of conversion agreements at a fair value of $8,584. The Company issued 150,448,490 shares of common stock upon conversion of $875,000 of preferred stock. The Company redeemed 182,145,203 shares of common stock at a market price of $0.01 per share $1,802,443. Non-controlling Interest As of March 31, 2024, WODI had March 31, 2024 WODI common stock holders Ownership % OriginClear, Inc. 90.83 % Prior Reg A Holders 0.19 % Prior Series A Holders 3.87 % Prior Series B Holders 5.11 % Total 100 %

Restricted Stock Grants and War

Restricted Stock Grants and Warrants	3 Months Ended
	Mar. 31, 2024
Restricted Stock Grants and Warrants [Abstract]
RESTRICTED STOCK GRANTS AND WARRANTS	5. RESTRICTED STOCK GRANTS AND WARRANTS Restricted Stock Grants to CEO, the Board, Employees and Consultants Between May 12, 2016, and August 4, 2022, the Company entered into Restricted Stock Grant Agreements (“the RSGAs”) with its Chief Executive Officer, the Board, Employees and Consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGAs are performance based shares. The RSGAs provide for the issuance of shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $ for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, and b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization ), calculated in accordance with generally accepted accounting principles, equals or exceeds $ for the trailing twelve month period as reported in the Company’s SEC Reports. The Company has not recognized any costs associated with the milestones, because achievement is not probable. On August 14, 2019, the Board of Directors approved an amendment to the RSGAs to include an alternative vesting schedule for the Grantees and on January 26, 2022, the Company amended the procedures for processing the RSGAs. If the fair market value of the Company’s common stock on the date the shares are vested is less than the fair market value of the Company’s common stock on the effective date of the RSGAs, then the number of vested shares issuable (assuming all conditions are satisfied per terms of the alternative vesting schedule) shall be increased so that the aggregate fair market value of vested shares issuable on the vesting date equals the aggregate fair market value that such number of shares would have had on the effective date. Upon the occurrence of a Company performance goal, the right to participate in the alternate vesting schedule will terminate, and the vesting of the remaining unvested shares will be as set forth under the RSGAs. Shares are issued under the . During the three months ended March 31, 2024, upon qualifying under the alternative vesting schedule, the Company issued an aggregate of 20,937,829 shares relating to the RSGAs and recognized an aggregate expense of $169,596 which is reflected on the financial statements as stock-based compensation. Warrants During the three months ended March 31, 2024, the Company issued 1,427,049 warrants for proceeds in the amount of $426,230 and issued 2,020,000 purchase warrants associated with the preferred stocks. A summary of the Company’s warrant activity and related information follows for the three months ended March 31, 2024: 3/31/2024 Number of Weighted Outstanding - beginning of period 64,401,089 $ 0.1383 Granted 2,020,000 $ 0.125 Exercised - - Expired - - Outstanding - end of period 66,421,089 $ 0.1379 At March 31, 2024, the weighted average remaining contractual life of warrants outstanding: Weighted Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.02 600,000 600,000 2.42 $ 0.0275 8,727,273 8,727,273 7.16 $ 0.10 2,500,000 2,500,000 2.89 $ 0.125 49,273,816 49,273,816 2.76 - 5.0 $ 0.25 3,760,000 3,760,000 2.72 - 2.75 $ 1.00 1,560,000 1,561,500 0.25 - 0.71 66,421,089 66,421,089 The derivative liability recognized in the financial statements for the warrants as of March 31, 2024 was $457,304. At March 31, 2024, the aggregate intrinsic value of the warrants outstanding was $0.

Convertible Promissory Notes

Convertible Promissory Notes	3 Months Ended
	Mar. 31, 2024
Convertible Promissory Notes [Abstract]
CONVERTIBLE PROMISSORY NOTES	6. CONVERTIBLE PROMISSORY NOTES OriginClear, Inc. As of March 31, 2024, the outstanding convertible promissory notes are summarized as follows: Convertible Promissory Notes $ 2,617,692 Less current portion 597,945 Total long-term liabilities $ 2,019,747 On various dates from November 2014 through April 2015, the Company issued unsecured convertible promissory notes (the “2014-2015 Notes”), that matured on various dates and were extended for an additional sixty (60) months from the effective date of each Note. The 2014-2015 Notes bear interest at 10% per year. The maturity dates were extended to November 2023 through April 2026. The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes. In addition, for as long as the 2014-2015 Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the 2014-2015 Notes or such other convertible notes or a term was not similarly provided to the purchaser of the 2014-2015 Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the 2014-2015 Notes and such other convertible notes. The conversion feature of the 2014-2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2014-2015 Notes. As of March 31, 2024, the 2014-2015 Notes had an aggregate remaining balance of $683,700 which is long term. The unsecured convertible promissory notes (the “OID Notes”) had an aggregate remaining balance of $184,124, plus accrued interest of $13,334. The OID Notes included an original issue discount and one-time interest, which has been fully amortized. The OID Notes matured on June 30, 2023, which were extended to June 30, 2028. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of $30,620. After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the OID Notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the OID Notes. During the year ended December 31, 2023, an addendum to the OID Notes was effectuated to accrue interest on a monthly basis. As of March 31, 2024, the remaining balance on the OID Notes was $62,275, which is long term. The Company issued various, unsecured convertible promissory notes (the “2015 Notes”), on various dates with the last of the 2015 Notes being issued in August 2015. The 2015 Notes matured and were extended from the date of each tranche through maturity dates ending on February 2026 through August 2026. The 2015 Notes bear interest at 10% per year. The 2015 Notes are convertible into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015 Notes. The conversion feature of the 2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015 Notes. As of March 31, 2024, the 2015 Notes had an aggregate remaining balance of $1,200,000, which is long term. The Company issued a convertible note (the “Dec 2015 Note”) in exchange for accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. The Dec 2015 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Dec 2015 Note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Dec 2015 Note and recognized as interest expense in the financial statements. On January 1, 2016, the Dec 2015 Note met the criteria of a derivative and was accounted for under ASC 815. The Dec 2015 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of March 31, 2024, the remaining balance on the Dec 2015 Note was $167,048, which is short term. The Company issued a convertible note (the “Sep 2016 Note”) in exchange for accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the date of the issuance, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. As of March 31, 2024, the remaining balance on the Sep 2016 Note was $430,897, which is short term. The Company entered into an unsecured convertible promissory note (the “Nov 20 Note”), on November 19, 2020 in the amount of $50,000. The Company received funds in the amount of $50,000. The Nov 20 Note had an original maturity date of November 19, 2021 and was extended for an additional sixty (60) months from the maturity date. The Nov 20 Note bears interest at 10% per year. The Nov 20 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Nov 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. As of March 31, 2024, the remaining balance on the Nov 20 Note was $13,772, which is long term. The Company entered into an unsecured convertible promissory note (the “Jan 21 Note”), on January 25, 2021 in the amount of $60,000. The Company received funds in the amount of $60,000. The Jan 21 Note had an original maturity date of January 25, 2022 and was extended for an additional sixty (60) months from the maturity date. The Jan 21 Note bears interest at 10% per year. The Jan 21 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of (a) $0.05 per share, (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Jan 25 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. As of March 31, 2024, the balance of the Jan 21 Note was $60,000, which is long term. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations. The derivative liability recognized in the financial statements for the convertible promissory notes as of March 31, 2024 was $20,052,649. Water On Demand, Inc. During the three months ended March 31, 2024, WODI raised capital in the amount of $960,000 and issued convertible secured promissory notes to investors with 10% interest per annum. Also during the period ended March 31, 2024, per settlement, conversion and redemption agreements with WODI shareholders, an aggregate of 83,352,197 shares of the Parent Company’s common stock were redeemed at the closing share prices on the dates of the convertible secured promissory note agreements, and this fair value of redeemed common stock was added to the cash value of the shareholders’ investments to purchase WODI convertible secured promissory notes. The loss relating to these settlement and conversion agreements of

Revenue from Contracts with Cus

Revenue from Contracts with Customers	3 Months Ended
	Mar. 31, 2024
Revenue from Contracts with Customers [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	7. REVENUE FROM CONTRACTS WITH CUSTOMERS Equipment Contracts Revenues and related costs on equipment contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. The following table represents a disaggregation of revenue by type of good or service from contracts with customers for the three months ended March 31, 2024 and 2023. Three Months Ended March 31, 2024 2023 Equipment Contracts $ 363,358 $ 926,190 Component Sales 206,387 198,391 Waste Water Treatment Systems - 791,075 Pump Stations 296,360 75,615 Rental Income 6,573 6,573 Services Sales 70,534 8,550 Commission & Training 225 - $ 943,437 $ 2,006,394 The above table reflects aggregate revenue of $6,573 and $6,573 from continued operations for the three months ended March 31, 2024 and 2023, respectively, and aggregate revenue of $936,864 and $1,999,821 from discontinued operations for the three months ended March 31, 2024 and 2023, respectively. Revenue recognition for other sales arrangements, such as sales for components, and service sales will remain materially consistent. Contract assets represents revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The contract asset for the three months ended March 31, 2024 and the year ended December 31, 2023, was $353,311 and $445,102, respectively. The contract liability for the three months ended March 31, 2024 and the year ended December 31, 2023, was $1,798,364 and $1,346,366, respectively.

Financial Assets

Financial Assets	3 Months Ended
	Mar. 31, 2024
Financial Assets [Abstract]
FINANCIAL ASSETS	8. FINANCIAL ASSETS Fair value investment in Securities On May 15, 2018, the Company received 4,000 shares of WTII Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into one thousand (1,000) shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of June 30, 2018. As of March 31, 2024, the fair value of the preferred shares was $3,200, and had a loss in fair value of $0. On November 12, 2021, the Company served a conversion notice to WTII and was issued an aggregate of 45,208,649 shares of WTII common stock. As of March 31, 2024, the investment in securities was recorded at fair value in the amount of $63,292, with an unrealized gain of $27,125.

Loans Payable

Loans Payable	3 Months Ended
	Mar. 31, 2024
Loans Payable [Abstract]
LOANS PAYABLE	9. LOANS PAYABLE Secured Loans Payable In 2018, the Company entered into short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $ , which included finance cost of $ . The finance costs were amortized over the terms of the loans, which had various maturity dates ranging from October 2018 through February 2019. As of December 31, 2020, the finance cost was fully amortized. The term of the loans ranged from two months to six months. The net balance as of March 31, 2024 was $ . On December 6, 2023, the Company entered into short term loan arrangement with a lender secured by the Company’s assets in the amount of $149,900 which included finance cost of $59,900 which was expensed upon initiation of the loan, with a net amount of $90,000 received by the Company. The loan was fully paid off during the three months ended March 31, 2024 and as of March 31, 2024, the balance outstanding is $0. Small Business Administration Loan On June 12, 2020, the Company received an Economic Injury Disaster Loan (the “EIDL”) in the amount of $150,000. Following the deferral period for the EIDL, the Company started to repay the principal amount, with interest, on a monthly basis. As of March 31, 2024, the remaining balance on the EIDL was $146,557.

Water on Demand Inc. (_WODI_)

Water on Demand Inc. (‘WODI’)	3 Months Ended
	Mar. 31, 2024
Water on Demand Inc. (‘WODI’) [Abstract]
WATER ON DEMAND INC. (‘WODI’)	10. WATER ON DEMAND INC. (“WODI”) Water On Demand, Inc. (“WODI”) was incorporated in the state of Nevada on April 22, 2022. WODI, with the support of its parent, OriginClear, Inc (the “Company”), is developing a new outsourced water treatment business called “Water On Demand”: or “WOD”. The WOD model intends to offer private businesses the ability to pay for water treatment and purification services on a per-gallon basis. This is commonly known as Design-Build-Own-Operate or “DBOO”. WODI intends to work with regional water service companies to build and operate the water treatment systems it finances. On November 16, 2022, WODI filed a Form 1-A Offering Circular for an offering under Regulation A (the “WODI Reg A Offering”) of the Securities Act of 1933 with the U.S. Securities and Exchange Commission. The purpose of the WODI Reg A Offering is to allow potential investors the opportunity to invest directly in WODI. The Offering had a minimum investment of $1,000 per investor and was conducted on a best-efforts basis. An aggregate of 12,000 shares were sold for total proceeds of $60,000 under the WODI Reg A Offering. The WODI Reg A Offering was suspended in June 2023. On December 22, 2022, WODI entered into a Membership Interest Purchase and Transfer Agreement (the “Purchase Agreement”) with Ka Wai Cheung, Koon Lin Chan, and Koon Keung Chan (each a “Seller”, and collectively, the “Sellers”) and Fortune Rise Sponsor LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which WODI purchased 100 membership interests in the Sponsor (“Purchased Interests”) from the Sellers, which constitutes 100% of the membership interests in the Sponsor. The Sponsor owns 2,343,750 shares out of 2,443,750 shares of the issued and outstanding shares of Class B common stock (the “Class B Common Stock”) of Fortune Rise Acquisition Corporation, a Delaware Corporation (“FRLA” or the “SPAC”). On December 29, 2022, the Company announced that its subsidiary, Water On Demand, Inc. had closed its acquisition of Fortune Rise Sponsor, LLC, which is the sponsor of Fortune Rise Acquisition Corp. On December 22, 2022, WODI paid a total of $1,137,267 to the Sellers of Fortune Rise Sponsor, LLC which included a total of $400,000 to purchase the membership interest in Class B Common Stock of FRLA and $737,267 for compensating the payment made by the Sellers on November 4, 2022, towards the first extension of the SPAC through February 5, 2023. In connection with the Extension Payment, FRLA issued unsecured promissory notes to the Sellers. As of December 31, 2022, the $737,267 amount was reflected as Notes Payable to related party on the consolidated balance sheet of the SPAC. To acquire the equity interests in FRLA for the purchase price of $400,000, WODI issued convertible secured promissory notes to investors at 10% interest per annum. Per the terms and conditions of the convertible promissory note, all unpaid principal, together with any unpaid and accrued interest shall be due and payable on the earlier of the twelve (12) month of the date of the Note (the “Maturity Date”) (provided, WODI shall have the option to extend the Maturity Date for up to two (2) six-month extensions), or (ii) when, upon the occurrence and during the continuance of an Event of Default. FRLA is a blank check company incorporated in February 2021 as a Delaware corporation formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. FRLA is a “shell company” as defined under the Exchange Act of 1934, as amended, because it has no operations and nominal assets consisting almost entirely of cash. The SPAC will not generate any operating revenues until after the completion of its initial business combination, at the earliest. On January 5, 2023, WODI signed a non-binding Letter of Intent (the “LOI”) with Fortune Rise Acquisition Corporation, (“FRLA” collectively with WODI, the “Parties”). The LOI is not binding on the Parties and is intended solely to guide good-faith negotiations toward a definitive business combination agreement. The Parties will work together in good faith with their respective advisors to agree on a structure for the business combination that is most expedient to the consummation of the acquisition, which may result in a new (merged) entity. Pursuant to the LOI, if a business combination were to be consummated and approved, all of the outstanding equity securities of WODI, including all shares of common stock, preferred stock, outstanding options and warrants will convert into new equity of the merged entity. On February 7, 2023, FRLA and OriginClear Inc. announced that WODI deposited $977,500 (the “Second Extension Payment”) into FRLA’s trust account for its public shareholders, representing $0.10 per public share, which enables FRLA to extend the period of time it has to consummate its initial business combination by an additional three months from February 5, 2023 to May 5, 2023 (the “Second Extension”). WODI assumed the obligation to make any necessary extension payments in connection with the extension of the period of time in which the SPAC may consummate its initial business combination as described in the SPAC’s S-1 Registration Statement, including the three-month extension from November 5, 2022 to February 5, 2023, the Second Extension for an additional three months from February 5, 2023 to May 5, 2023 and a final extension for an additional six months from May 5, 2023 to November 5, 2023. On April 10, 2023, at the Special Meeting, a total of 10,514,410 (or 81.61%) of FRLA’s issued and outstanding shares of Class A common stock and Class B common stock held of record as of March 3, 2023, were present either in person or by proxy, which constituted a quorum. In that FRLA shareholders agreed to an extension of the period of time it has to consummate its initial business combination by an additional six months from May 5, 2023 to November 5, 2023. FRLA’s stockholders voted on to approve and adopt the extension amendment which received sufficient votes (more than 65%) for approval. On April 14, 2023, WODI entered into an Asset Purchase Agreement with the Company, whereby it agreed to purchase all of the assets related to the Company’s “Modular Water Service” business, including licenses, technology, intellectual property, contracts, business models, patents and other assets in exchange for 6,000,000 shares of WODI common stock. The assets included MWS accounts receivables and accounts payables as of April 14, 2023 and an assignment of the Company’s existing global master license to the patents of inventor Daniel M. Early, P.E., who heads MWS, and the right to file patents for all additional inventions since 2018, when OriginClear created the MWS unit. Beginning on the Effective Date, all MWS transactions including revenue, accounts payable and accounts receivable were transferred from the Company’s Progressive Water Treatment, Inc. (“PWT”) subsidiary over to the Company’s WODI subsidiary. On September 21, 2023, WODI entered into a merger agreement with PWT to create better enterprise value for a potential merger opportunity with FRLA and a plan of merger agreement (the “PWT-WODI merger agreement”) was entered into between WODI and PWT. Per the PWT-WODI merger agreement, all shares of WODI common and preferred stock were exchanged for shares of PWT common stock as merger consideration. WODI convertible notes and WODI Restricted Stock Grants were assumed by PWT and remain outstanding. In connection with the merger with WODI, PWT changed its name to Water on Demand, Inc. Before issuing common stock to WODI stockholders in the PWT Merger, PWT had 10,000,000 common shares issued and outstanding, which were fully owned by OCLN. Post PWT-WODI merger, OCLN received an aggregate of 2,171,068 shares of the Water On Demand, Inc. On September 28, 2023, the Letter of Intent (“LOI”) executed on January 5, 2023 with WODI was amended to designate PWT as the new target of the acquisition. Under the amended LOI, FRLA proposed to acquire all the outstanding securities of PWT entity, based on certain material financial and business terms and conditions being met. The LOI is not binding on the parties and is intended solely to guide good-faith negotiations toward definitive agreements. On October 24, 2023 FRLA and WODI entered into a definitive business combination agreement (the “BCA”). On October 25, 2023, at the Special Meeting, a total of 5,687,847 (or 84.59%) of FRLA’s issued and outstanding shares of Class A common stock and Class B common stock held of record, were present either in person or by proxy, which constituted a quorum. FRLA shareholders approved a proposal to extend the period of time FRLA has to consummate its initial business combination by an additional one year from November 5, 2023 to November 5, 2024, by up to twelve one-month extensions, subject to certain conditions Promissory Notes Since buying the sponsorship interest in the SPAC on December 22, 2022 through March 31, 2024, WODI and the Company made payments on behalf of the SPAC in the aggregate amount of $4,619,985. As of March 31, 2024, WODI and the Company received an aggregate of $4,619,985 in unsecured promissory notes (the “SPAC Notes”) from the SPAC in exchange for the payments made on behalf of the SPAC to meet its operating expenses and the extension payments. The SPAC Notes are non-interest bearing and payable (subject to the waiver against SPAC trust provisions) on the earlier of (i) consummation of the SPAC initial business combination; or (ii) the date of the liquidation of the SPAC. The principal balance of each SPAC Note may be prepaid at any time, at the election of the SPAC. As of the date of this filing, the SPAC has been extended through November 5, 2024, to give the Company adequate time to complete all the necessary administrative and regulatory steps, including filing of the registration statement and timely respond to satisfy potential comments, from regulatory bodies to consummate the business combination. Management estimates the likelihood of completing the business combination at 75%. Impairment of receivable Although the payments made on behalf of the SPAC are amounts receivable to WODI, for the period ended March 31, 2024, WODI considered the aggregate amount of $590,000 for the SPAC Notes to be impaired and recorded it as an expense on the consolidated income statements, as it is deemed probable that the SPAC may not have funds to pay back with interest all of the Class A shareholders and WODI for the amounts advanced to the SPAC. In the event of WODI successfully merging with the SPAC, all amounts paid by WODI on behalf of the SPAC, including any future payments made until such merger is fully consummated will be received back by WODI. Recording of membership interest: As of March 31, 2024, WODI recorded the purchase of Class B Founder Shares at lower of cost or market at $400,000 on the consolidated balance sheet as other asset held-for-sale. Impairment analysis for Class B Common Founder Shares as at March 31, 2024 The Company retained an independent valuation firm for the purpose of conducting a valuation of the fair value of Sponsor Founder Shares (Class B) of Fortune Rise Acquisition Corp. as of December 31, 2023. The independent firm (i) evaluated and analyzed various Sponsor Founder Shares of Fortune Rise Acquisition Corp. (“FRLA”); (ii) assessed the terms including various redemption and liquidation features considering each of the Company’s financial plans and market conditions; and (iii) determined the underlying value to be assigned to the FRLA Sponsor Founder Shares as of the Date of Valuation and evaluated the FRLA Sponsor Founder Shares for impairment by performing the following procedures: ● Analyzed the Company’s S-4 filing, business combination agreement and other documentation. ● Developed Monte Carlo Model that values the FRLA Sponsor Founder Shares based on a multipath random event model and future projections of the various potential outcomes. The Monte Carlo Model simulation included 50,000 iterations and simulated the stock price, the timing of the business combination, and the timing of the lapse of the transfer restrictions. ● Developed the discounted cash flow from the sale of the securities at the time the restrictions terminated. ● Probability weighted the cash flow, discounted for lack of marketability. ● Valued the FRLA Sponsor Founder Shares as of the date of valuation. Based on the procedures performed the independent valuation firm concluded that the value of FRLA Sponsor Founder Shares was not impaired. Restricted Stock to WODI Board, Employees and Consultants Between August 12, 2022, and August 3, 2023, WODI entered into Restricted Stock Grant Agreements (the “WODI RSGAs”) with its members of the Board, employees, and consultants to create management incentives to improve the economic performance of WODI and to increase its value. WODI RSGAs provide for the issuance of up to 15,550,000 shares of WODI common stock provided certain milestones and vesting are met in certain stages. . WODI has not recognized any costs associated the WODI RSGAs because milestones and vesting have not been achieved. As the milestones are achieved, the shares shall become eligible for vesting and issuance. On September 21, 2023, per the Merger Plan Agreement and per the conversion ratio of 0.19737 established in the Merger Plan Agreement, the 15,550,000 total issuable shares under the WODI RSGAs were converted to 3,069,100 total issuable shares. On October 23, 2023, certain WODI RSGAs were canceled and new WODI RSGAs were issued. As of March 31, 2024, there were 2,581,344 total issuable shares under the WODI RSGAs. As the milestones are achieved, the shares shall become eligible for vesting and issuance. During the three months ended March 31, 2024, no issuable shares under the WODI RSGAs vested and no costs associated with the milestones were recognized because achievement is not probable.

Line of Credit

Line of Credit	3 Months Ended
	Mar. 31, 2024
Line of Credit [Abstract]
LINE OF CREDIT	11. LINE OF CREDIT During the year ended December 31, 2023, the Company obtained 12 month credit lines in the aggregate amount of $345,875, with an interest rate of 26.07%. Through March 31, 2024, the Company paid principal in the amount of $256,107, leaving a principal balance of $89,768 as of March 31, 2024.

Assets Held for Sale _ Continui

Assets Held for Sale – Continuing Operations	3 Months Ended
	Mar. 31, 2024
Assets Held for Sale – Continuing Operations [Abstract]
ASSETS HELD FOR SALE – CONTINUING OPERATIONS	12. ASSETS HELD FOR SALE – CONTINUING OPERATIONS On March 1, 2021, the Company issued an aggregate of 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per terms of a Securities Purchase Agreement (the “SPA”). Per the SPA, the Company agreed to sell to Purchaser, and Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share per terms of the SPA, which were exercisable at any time in whole or in part. The purchaser and the Company agreed that in lieu of the purchase price for the Series T, the Purchaser transferred to the Company real property, with an aggregate value agreed to be $630,000 based on an appraisal from an international independent company at that time. The real property consisted of real estate in Buenos Aires Argentina. The real property exchanged for 630 shares of Series T was recorded at $630,000 at that time. Based on indicator of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the asset for sale from $630,000 to $514,000 and recorded an impairment of $116,000 in the consolidated financial statements During the period ended December 31, 2022, after evaluating several offers, the Company considered an offer for $400,000, which was $114,000 below the previously adjusted value and was indicative of the real estate market conditions in Buenos Aires Argentina. Based on that indicator of impairment, during the year ended December 31, 2022, the Company further adjusted the previous value of the asset for sale from $514,000 to $400,000 on the balance sheet and recorded an impairment of $114,000 in the consolidated financial statements. All Series T preferred stock was converted and the warrants associated with the Series T expired during the period ended December 31, 2022. In January 2023, the Company accepted the offer and on April 8, 2023, a deed was executed for the sale of the property for $400,000. The agreed upon payment terms were; $235,000 initial payment and the remaining $165,000 to be paid over fifteen monthly installments of $11,000 each. The initial payment was received by SMS Argentina (“SMS”), an accounting and consulting firm that was appointed by the Company as the Power of Attorney for the property. From the proceeds, SMS remitted taxes due on the transaction to the Federal Administration of Public Income (“AFIP”), which administers taxation in Argentina. On June 21, 2023, the Company received a payment of $164,935, net of all taxes assessed by AFIP and other closing fees associated with the sale of the property totaling $65,493 and recorded a receivable of $169,572 for the remaining balance. Between July 1, 2023 through March 31, 2024, the Company received additional payments totaling $103,572. As of March 31, 2024, the balance of the receivable was $66,000 which is reflected on the consolidated financial statements

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	13. COMMITMENTS AND CONTINGENCIES Facility Rental – Related Party Our Dallas based subsidiary, PWT, rents an approximately 12,000 square foot facility located at 2535 E. University Drive, McKinney, TX 75069, with a current monthly rent of $8,500. Warranty Reserve Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000 for three months ended March 31, 2024 and the year ending December 31, 2023. Litigation There are no material updates to the litigation matters with Process Solutions, Inc.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	14. SUBSEQUENT EVENTS Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events: Between April 1, 2024 and May 1, 2024, the Company issued to consultants an aggregate of 2,969,808 shares of the Company’s common stock for services. Between April 3, 2024 and April 24, 2024, the Company entered into settlement agreements with certain accredited investors pursuant to which the Company issued an aggregate of 102,883,285 shares of the Company’s common stock in settlement of certain claims with such persons. Between April 3, 2024 and May 1, 2024, an aggregate of 42,975,239 shares of common stock were redeemed by the Company, and the redemption amount, together with cash paid by the redeeming stockholders, were used by the stockholders to purchase convertible secured promissory notes from WODI. Between April 3, 2024 and May 1, 2024, holders of the Company’s Series Y preferred stock converted an aggregate of 1.3 Series Y shares into an aggregate of 18,560,607 shares of the Company’s common stock. Between April 5, 2024 and May 6, 2024, WODI made payments on behalf of the SPAC in the aggregate amount of $255,000. Between April 9, 2024 and April 12, 2024, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 1.3 shares of the Company’s Series Y preferred stock for an aggregate purchase price of $131,300. The Company also issued an aggregate of 1,050,400 warrants to purchase shares of its common stock to these investors. On May 14, 2024, holders of the Company’s Series O preferred stock converted an aggregate of 5 Series O shares into an aggregate of 965,252 shares of the Company’s common stock.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (15,896,283)	$ (491,534)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2024
Summary of Significant Accounting Polices [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its subsidiaries Water On Demand, Inc. (‘WODI’), (which consists of operating divisions Progressive Water Treatment, Modular Water Systems and Water On Demand), Water On Demand #1, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities.
Cash and Cash Equivalent	Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Net Earnings (Loss) per Share Calculations	Net Earnings (Loss) per Share Calculations Basic loss per share calculation is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted earnings per share were not the same as the basic loss per share for the three months ended March 31, 2024 and 2023, respectively, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. For the Three Months Ended 2024 2023 Loss to common shareholders (Numerator) – continuing operations $ (13,659,322 ) $ 3,789,931 Loss to common shareholders (Numerator) – related to assets held-for sale (2,236,961 ) (4,188,741 ) Basic and diluted weighted average number of common shares outstanding (Denominator) 1,443,544,402 1,062,100,064 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive.
Revenue Recognition	Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable - WODI	Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was $368,917 and $379,335 as of March 31, 2024 and December 31, 2023, respectively. The net contract receivable balance was $751,130 and $1,509,504 at March 31, 2024 and December 31, 2023, respectively.
Indefinite Lived Intangibles and Goodwill Assets	Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at March 31, 2024 and 2023, respectively, and determined there was no impairment of indefinite lived intangibles and goodwill.
Prepaid Expenses	Prepaid Expenses The Company records expenditures that have been paid in advance as prepaid expenses. The prepaid expenses are initially recorded as assets, because they have future economic benefits, and are expensed at the time the benefits are realized. The prepaid expenses balance was $11,936 and $0 at March 31, 2024 and December 31, 2023, respectively.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years 3/31/2024 12/31/23 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 66,493 66,493 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 607,012 607,012 Less accumulated depreciation (467,539 ) (460,277 ) Net Property and Equipment $ 139,473 $ 146,735 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that the facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the three months ended March 31, 2024 and 2023, was $6,582 and $6,690, respectively.
Other Assets	Other Assets Long Term Asset Held for Sale On March 1, 2021, the Company issued an aggregate of 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per terms of a Securities Purchase Agreement (the “SPA”). Per the SPA, the Company agreed to sell to Purchaser, and Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share per terms of the SPA, which were exercisable at any time in whole or in part. The purchaser and the Company agreed that in lieu of the purchase price for the Series T, the Purchaser transferred to the Company real property, with an aggregate value agreed to be $630,000 based on an appraisal from an international independent company at that time. The real property consisted of residential real estate in Buenos Aires Argentina valued at $580,000, and eight undeveloped lots valued at $50,000 in Terralta private neighborhood development. The real property exchanged for 630 shares of Series T was recorded at $630,000 and reflected on the balance sheet as a long term asset for sale at that time. The real property was listed for sale beginning in July 2021. However, based on indicators of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the asset for sale from $630,000 to $514,000 and recorded an impairment of $116,000 in the consolidated financial statements During the period ended December 31, 2022, after evaluating several offers, the Company considered an offer for $400,000, which was $114,000 below the previously adjusted value and was indicative of the real estate market conditions in Buenos Aires Argentina. Based on that indicator of impairment, during the year ended December 31, 2022, the Company further adjusted the previous value of the asset for sale from $514,000 to $400,000 on the balance sheet and recorded an impairment of $114,000 in the consolidated financial statements. All Series T preferred stock was converted and the warrants associated with the Series T expired during the period ended December 31, 2022. In January 2023, the Company accepted the offer and on April 8, 2023, a deed was executed for the sale of the property for $400,000. The agreed upon payment terms were; $235,000 initial payment and the remaining $165,000 to be paid over fifteen monthly installments of $11,000 each. The initial payment was received by SMS Argentina (“SMS”), an accounting and consulting firm that was appointed by the Company as the Power of Attorney for the property. From the proceeds, SMS remitted taxes due on the transaction to the Federal Administration of Public Income (“AFIP”), which administers taxation in Argentina. On June 21, 2023, the Company received a payment of $164,935, net of all taxes assessed by AFIP and other closing fees associated with the sale of the property totaling $65,493 and recorded a receivable of $169,572 for the remaining amount on the consolidated financial statements as of June 30, 2023. Between July 1, 2023 through March 31, 2024, the Company received additional payments totaling $103,572. As of March 31, 2024, the balance of the receivable was $66,000 which is reflected on the consolidated financial statements.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants vest immediately and the total stock-based compensation charge is recorded in the period of the measurement date.
Accounting for Derivatives	Accounting for Derivatives The Company evaluates all its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not to recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2024, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of March 31, 2024. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, March 31, 2024 $ 66,492 $ 66,492 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, March 31, 2024 $ 20,509,953 $ - $ - $ 20,509,953 The derivative liabilities consist of $20,052,649 for convertible notes outstanding and $457,304 for warrants outstanding for an aggregate of $20,509,953. The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of December 31, 2023 $ 7,742,759 Net loss on conversion of debt and change in derivative liabilities 12,767,194 Balance as of March 31, 2024 $ 20,509,953 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 3/31/2023 Risk free interest rate 4.53% – 4.96% Stock volatility factor 141% – 219% Weighted average expected option life 6 mos - 5 yrs Expected dividend yield None
Segment Reporting	Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.
Marketable Securities	Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income.
Licensing agreement	Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered.
Reclassification	Reclassification Certain amounts in the prior period financial statements have been reclassified to conform to the presentation used in the current financial statements for comparative purpose. There was no material effect on the Company’s previously issued financial statements.
Work-in-Process	Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Polices (Tables)	3 Months Ended
	Mar. 31, 2024
Summary of Significant Accounting Polices [Abstract]
Schedule of Loss Per Share Anti-Dilutive Effect	The Company’s diluted earnings per share were not the same as the basic loss per share for the three months ended March 31, 2024 and 2023, respectively, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. For the Three Months Ended 2024 2023 Loss to common shareholders (Numerator) – continuing operations $ (13,659,322 ) $ 3,789,931 Loss to common shareholders (Numerator) – related to assets held-for sale (2,236,961 ) (4,188,741 ) Basic and diluted weighted average number of common shares outstanding (Denominator) 1,443,544,402 1,062,100,064
Schedule of Furniture and Equipment are Depreciated on the Straight-Line Method	Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years
Schedule of Property Plant and Equipment	3/31/2024 12/31/23 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 66,493 66,493 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 607,012 607,012 Less accumulated depreciation (467,539 ) (460,277 ) Net Property and Equipment $ 139,473 $ 146,735
Schedule of Level Within the Fair Value Investments and Liabilities	The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of March 31, 2024. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, March 31, 2024 $ 66,492 $ 66,492 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, March 31, 2024 $ 20,509,953 $ - $ - $ 20,509,953
Schedule of Reconciliation of the Derivative Liability for Which Level 3 inputs	The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of December 31, 2023 $ 7,742,759 Net loss on conversion of debt and change in derivative liabilities 12,767,194 Balance as of March 31, 2024 $ 20,509,953
Schedule of Fair Market Value of the Derivative Liability	The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 3/31/2023 Risk free interest rate 4.53% – 4.96% Stock volatility factor 141% – 219% Weighted average expected option life 6 mos - 5 yrs Expected dividend yield None

Wodi Assets and Liabilities H_2

Wodi Assets and Liabilities Held-for-Sale – Discontinuing Operations (Tables)	3 Months Ended
	Mar. 31, 2024
Wodi Assets and Liabilities Held-for-Sale – Discontinuing Operations [Abstract]
Schedule of Assets and Liabilities Held-For-Sale	Assets and Liabilities Held-For-Sale March 31, December 31, 2024 2023 CURRENT ASSETS Cash $ 502,820 $ 374,192 Contracts receivable, net allowance of $368,917 and $379,335, respectively (See Note 2) 751,130 1,509,504 Contract assets (See Note 7) 353,311 455,102 Total Current Assets Held-For-Sale 1,607,261 2,338,798 NET PROPERTY AND EQUIPMENT HELD-FOR-SALE 2,689 3,370 NON-CURRENT ASSETS HELD-FOR SALE SPAC Class B common shares purchase cost (See Note 10) 400,000 400,000 CURRENT LIABILITIES HELD-FOR-SALE Accounts payable and other payable $ 982,435 $ 1,335,211 Accrued expenses 1,521,023 1,103,159 Contract liabilities (See Note 7) 1,798,364 1,346,366 Tax liability 83(b) 13,600 13,600 Customer deposit 143,503 143,503 Warranty reserve 20,000 20,000 Line of credit (See Note 11) 89,768 178,808 Secured Loans payable - 110,695 Convertible secured promissory notes (See Note 6) 18,381,089 16,729,089 Total Current Liabilities Held-For-Sale $ 22,949,782 $ 20,980,431 Three Months Ended March 31, March 31, 2024 2023 Sales $ 936,864 $ 1,999,821 Cost of Goods Sold 1,055,940 1,875,319 Gross Profit (119,076 ) 124,502 Operating Expenses Selling and marketing expenses 62,324 17,603 General and administrative expenses 315,226 275,578 Depreciation and amortization expense 682 1,139 Total Operating Expenses 378,232 294,320 Loss from Operations (497,308 ) (169,818 ) OTHER INCOME (EXPENSE) Other income 809 142,797 Impairment of receivable from SPAC (590,000 ) (1,607,920 ) Conversion and settlement value added to note purchase agreements (See Note 6) (692,000 ) (2,505,339 ) Interest expense (458,462 ) (48,461 ) TOTAL OTHER (EXPENSE) INCOME (1,739,653 ) (4,018,923 ) NET LOSS FROM ASSETS-HELD-FOR-SALE $ (2,236,961 ) $ (4,188,741 )

Capital Stock (Tables)

Capital Stock (Tables)	3 Months Ended
	Mar. 31, 2024
Capital Stock [Abstract]
Schedule of Non-controlling Interest	As of March 31, 2024, WODI had March 31, 2024 WODI common stock holders Ownership % OriginClear, Inc. 90.83 % Prior Reg A Holders 0.19 % Prior Series A Holders 3.87 % Prior Series B Holders 5.11 % Total 100 %

Restricted Stock Grants and W_2

Restricted Stock Grants and Warrants (Tables)	3 Months Ended
	Mar. 31, 2024
Restricted Stock Grants and Warrants [Abstract]
Schedule of Warrant Activity	A summary of the Company’s warrant activity and related information follows for the three months ended March 31, 2024: 3/31/2024 Number of Weighted Outstanding - beginning of period 64,401,089 $ 0.1383 Granted 2,020,000 $ 0.125 Exercised - - Expired - - Outstanding - end of period 66,421,089 $ 0.1379
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding	At March 31, 2024, the weighted average remaining contractual life of warrants outstanding: Weighted Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.02 600,000 600,000 2.42 $ 0.0275 8,727,273 8,727,273 7.16 $ 0.10 2,500,000 2,500,000 2.89 $ 0.125 49,273,816 49,273,816 2.76 - 5.0 $ 0.25 3,760,000 3,760,000 2.72 - 2.75 $ 1.00 1,560,000 1,561,500 0.25 - 0.71 66,421,089 66,421,089

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	3 Months Ended
	Mar. 31, 2024
Convertible Promissory Notes [Abstract]
Schedule of Outstanding Convertible Promissory Notes	As of March 31, 2024, the outstanding convertible promissory notes are summarized as follows: Convertible Promissory Notes $ 2,617,692 Less current portion 597,945 Total long-term liabilities $ 2,019,747

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contracts with Customers [Abstract]
Schedule of Good or Service from Contracts with Customers	The following table represents a disaggregation of revenue by type of good or service from contracts with customers for the three months ended March 31, 2024 and 2023. Three Months Ended March 31, 2024 2023 Equipment Contracts $ 363,358 $ 926,190 Component Sales 206,387 198,391 Waste Water Treatment Systems - 791,075 Pump Stations 296,360 75,615 Rental Income 6,573 6,573 Services Sales 70,534 8,550 Commission & Training 225 - $ 943,437 $ 2,006,394

Basis of Presentation (Details)

Basis of Presentation (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Basis of Presentation [Abstract]
Revenue	$ 6,573	$ 6,573

Summary of Significant Accoun_3

Summary of Significant Accounting Polices (Details) - USD ($)				3 Months Ended	12 Months Ended
	Jun. 21, 2023	Apr. 08, 2023	Mar. 01, 2021	Mar. 31, 2024	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2023	Mar. 31, 2023
Summary of Significant Accounting Polices [Line Items]
Allowance for doubtful accounts				$ 368,917			$ 379,335
Contract receivable				751,130			1,509,504
Prepaid expenses				11,936			$ 0
Depreciation expense				$ 6,690	$ 6,582
Issued an aggregate (in Shares)				135
Common stock, per share (in Dollars per share)				$ 0.0001			$ 0.0001	$ 0.01
International independent company			$ 630,000
Real estate property value			580,000
Private development			$ 50,000
Real property share (in Shares)			630
Real property exchanged			$ 630,000
Impairment					114,000	$ 116,000
Sale of the property		$ 400,000
Initial payment		235,000
Installment amount		$ 11,000
Received payment	$ 164,935
Sale of property	65,493
Receivable	$ 169,572			$ 66,000
Additional payments				103,572
Derivative liabilities				20,052,649
Warrants outstanding				457,304
Aggregate derivative liabilities				$ 20,509,953
Minimum [Member]
Summary of Significant Accounting Polices [Line Items]
Real estate property value					114,000
Long term asset					400,000	630,000
Maximum [Member]
Summary of Significant Accounting Polices [Line Items]
Real estate property value					400,000
Long term asset					$ 514,000	$ 514,000
Series T Preferred Stock [Member]
Summary of Significant Accounting Polices [Line Items]
Issued an aggregate (in Shares)			630
Purchaser agreed to purchase (in Shares)			630
Common Stock [Member]
Summary of Significant Accounting Polices [Line Items]
Common stock, per share (in Dollars per share)			$ 0.05	$ 0.01
Warrant [Member]
Summary of Significant Accounting Polices [Line Items]
Acquire share (in Shares)			25,200,000

Summary of Significant Accoun_4

Summary of Significant Accounting Polices (Details) - Schedule of Loss Per Share Anti-Dilutive Effect - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule of Loss Per Share Anti-Dilutive Effect [Line Items]
Loss to common shareholders (Numerator) – continuing operations	$ (13,659,322)	$ 3,789,931
Loss to common shareholders (Numerator) – related to assets held-for sale	$ (2,236,961)	$ (4,188,741)
Basic weighted average number of common shares outstanding (Denominator) (in Shares)	1,443,544,402	1,062,100,064
Loss per share Assets-held-for-sale [Member]
Schedule of Loss Per Share Anti-Dilutive Effect [Line Items]
Loss to common shareholders (Numerator) – related to assets held-for sale	$ (2,236,961)	$ (4,188,741)

Summary of Significant Accoun_5

Summary of Significant Accounting Polices (Details) - Schedule of Loss Per Share Anti-Dilutive Effect (Parentheticals) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule of Loss Per Share Anti-Dilutive Effect [Line Items]
Diluted weighted average number of common shares outstanding (Denominator)	1,443,544,402	1,062,100,064

Summary of Significant Accoun_6

Summary of Significant Accounting Polices (Details) - Schedule of Furniture and Equipment are Depreciated on the Straight-Line Method	Mar. 31, 2024
Minimum [Member] | Machinery and equipment [Member]
Schedule of Furniture and Equipment are Depreciated on the Straight-Line Method [Line Items]
Estimated Life	5 years
Minimum [Member] | Furniture, fixtures and computer equipment [Member]
Schedule of Furniture and Equipment are Depreciated on the Straight-Line Method [Line Items]
Estimated Life	5 years
Minimum [Member] | Vehicles [Member]
Schedule of Furniture and Equipment are Depreciated on the Straight-Line Method [Line Items]
Estimated Life	3 years
Minimum [Member] | Leasehold improvements [Member]
Schedule of Furniture and Equipment are Depreciated on the Straight-Line Method [Line Items]
Estimated Life	2 years
Maximum [Member] | Machinery and equipment [Member]
Schedule of Furniture and Equipment are Depreciated on the Straight-Line Method [Line Items]
Estimated Life	10 years
Maximum [Member] | Furniture, fixtures and computer equipment [Member]
Schedule of Furniture and Equipment are Depreciated on the Straight-Line Method [Line Items]
Estimated Life	7 years
Maximum [Member] | Vehicles [Member]
Schedule of Furniture and Equipment are Depreciated on the Straight-Line Method [Line Items]
Estimated Life	5 years
Maximum [Member] | Leasehold improvements [Member]
Schedule of Furniture and Equipment are Depreciated on the Straight-Line Method [Line Items]
Estimated Life	5 years

Summary of Significant Accoun_7

Summary of Significant Accounting Polices (Details) - Schedule of Property Plant and Equipment - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	$ 607,012	$ 607,012
Less accumulated depreciation	(467,539)	(460,277)
Net Property and Equipment	139,473	146,735
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	383,569	383,569
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	66,493	66,493
Furniture [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	29,810	29,810
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	26,725	26,725
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	64,276	64,276
Demo Units [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	$ 36,139	$ 36,139

Summary of Significant Accoun_8

Summary of Significant Accounting Polices (Details) - Schedule of Level Within the Fair Value Investments and Liabilities	Mar. 31, 2024 USD ($)
Schedule of Level Within the Fair Value Investments and Liabilities [Line Items]
Investment at fair value-securities, March 31, 2024	$ 66,492
Derivative Liability, March 31, 2024	20,509,953
Level 1 [Member]
Schedule of Level Within the Fair Value Investments and Liabilities [Line Items]
Investment at fair value-securities, March 31, 2024	66,492
Derivative Liability, March 31, 2024
Level 2 [Member]
Schedule of Level Within the Fair Value Investments and Liabilities [Line Items]
Investment at fair value-securities, March 31, 2024
Derivative Liability, March 31, 2024
Level 3 [Member]
Schedule of Level Within the Fair Value Investments and Liabilities [Line Items]
Investment at fair value-securities, March 31, 2024
Derivative Liability, March 31, 2024	$ 20,509,953

Summary of Significant Accoun_9

Summary of Significant Accounting Polices (Details) - Schedule of Reconciliation of the Derivative Liability for Which Level 3 inputs	3 Months Ended
	Mar. 31, 2024 USD ($)
Schedule of Reconciliation of the Derivative Liability for Which Level 3 inputs [Abstract]
Balance as of December 31, 2023	$ 7,742,759
Net loss on conversion of debt and change in derivative liabilities	12,767,194
Balance as of March 31, 2024	$ 20,509,953

Summary of Significant Accou_10

Summary of Significant Accounting Polices (Details) - Schedule of Fair Market Value of the Derivative Liability	3 Months Ended
	Mar. 31, 2023
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected dividend yield	0%
Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate	4.53%
Stock volatility factor	141%
Weighted average expected option life	6 months
Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate	4.96%
Stock volatility factor	219%
Weighted average expected option life	5 years

Wodi Assets and Liabilities H_3

Wodi Assets and Liabilities Held-for-Sale – Discontinuing Operations (Details) $ in Millions	Oct. 24, 2023 USD ($)
Water on Demand, Inc [Member]
Wodi Assets and Liabilities Held-for-Sale – Discontinuing Operations [Line Items]
Equity valuation	$ 72

Wodi Assets and Liabilities H_4

Wodi Assets and Liabilities Held-for-Sale – Discontinuing Operations (Details) - Schedule of Assets and Liabilities Held-For-Sale - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Assets and Liabilities Held-For-Sale [Member]
CURRENT ASSETS
Cash	$ 502,820		$ 374,192
Contracts receivable, net allowance of $368,917 and $379,335, respectively (See Note 2)	751,130		1,509,504
Contract assets	353,311		455,102
Total Current Assets Held-For-Sale	1,607,261		2,338,798
NET PROPERTY AND EQUIPMENT HELD-FOR-SALE	2,689		3,370
NON-CURRENT ASSETS HELD-FOR SALE
SPAC Class B common shares purchase cost	400,000		400,000
CURRENT LIABILITIES HELD-FOR-SALE
Accounts payable and other payable	982,435		1,335,211
Accrued expenses	1,521,023		1,103,159
Contract liabilities	1,798,364		1,346,366
Tax liability	13,600		13,600
Customer deposit	143,503		143,503
Warranty reserve	20,000		20,000
Line of credit	89,768		178,808
Secured Loans payable			110,695
Convertible secured promissory notes	18,381,089		16,729,089
Total Current Liabilities Held-For-Sale	22,949,782		$ 20,980,431
Net Loss from Assets-Held-For-Sale [Member]
CURRENT LIABILITIES HELD-FOR-SALE
Sales	936,864	$ 1,999,821
Cost of Goods Sold	1,055,940	1,875,319
Gross Profit	(119,076)	124,502
Operating Expenses
Selling and marketing expenses	62,324	17,603
General and administrative expenses	315,226	275,578
Depreciation and amortization expense	682	1,139
Total Operating Expenses	378,232	294,320
Loss from Operations	(497,308)	(169,818)
OTHER INCOME (EXPENSE)
Other income	809	142,797
Impairment of receivable from SPAC	(590,000)	(1,607,920)
Conversion and settlement value added to note purchase agreements	(692,000)	(2,505,339)
Interest expense	(458,462)	(48,461)
TOTAL OTHER (EXPENSE) INCOME	(1,739,653)	(4,018,923)
NET LOSS FROM ASSETS-HELD-FOR-SALE	$ (2,236,961)	$ (4,188,741)

Capital Stock (Details) - Part-

Capital Stock (Details) - Part-1 - USD ($)					3 Months Ended
	Aug. 21, 2020	Aug. 14, 2018	Apr. 13, 2018	Mar. 14, 2017	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Capital Stock [Line Items]
Shares issued							18,645,028
Percentage of voting shares				51%
Preferred stock, share authorized					600,000,000	600,000,000
Common stock, shares outstanding					1,478,617,331	1,399,782,046
Series C Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock per share (in Dollars per share)				$ 0.0001
Purchase price of the series C preferred stock (in Dollars per share)				$ 0.1
Total purchase price series C preferred stock, shares				1,000
Aggregate shares					10
Series C Preferred Stock [Member] | Mr. Eckelberry [Member]
Capital Stock [Line Items]
Preferred stock, share outstanding					1,000
Series C Preferred Stock [Member] | OriginClear, Inc Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, shares outstanding						0
Series C Preferred Stock [Member] | Board of Directors Chairman [Member]
Capital Stock [Line Items]
Shares issued				1,000
Shares Issued, Price Per Share (in Dollars per share)				$ 0.0001
Series D-1 Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, shares outstanding					31,500,000	31,500,000
Preferred stock, share authorized			50,000,000
Convertible preferred stock, per share (in Dollars per share)			$ 0.0005
Percentage of common stock outstanding			4.99%
Increased common stock percentage			9.99%
Preferred stock, shares issued					31,500,000	31,500,000
Common Stock [Member]
Capital Stock [Line Items]
Shares issued							85,836,889
Common Stock [Member] | PWT [Member]
Capital Stock [Line Items]
Common stock, shares outstanding					31,500,000
Series F Preferred Stock [Member]
Capital Stock [Line Items]
Preferred stock, shares outstanding					50
Designated preferred stock issued		6,000
Preferred stock liquidation per share (in Dollars per share)		$ 1,000
Annual rate percentage		8%
Aggregate redemption price (in Dollars)					$ 50,000
Series Q Preferred Stock [Member]
Capital Stock [Line Items]
Shares issued					4,576,458
Preferred stock, shares outstanding					410
Percentage of common stock outstanding	4.99%
Preferred stock, shares issued					410
Designated preferred stock issued	2,000
Number of shares					10

Capital Stock (Details) - Par_2

Capital Stock (Details) - Part-2 - USD ($)					3 Months Ended
	Jun. 10, 2021	Apr. 30, 2021	Apr. 03, 2019	Jan. 16, 2019	Mar. 31, 2024	Dec. 31, 2023
Capital Stock [Line Items]
Preferred stock per share (in Dollars per share)					$ 0.0001	$ 0.0001
Series G Preferred Stock [Member]
Capital Stock [Line Items]
Designated preferred stock issued				6,000
Preferred stock per share (in Dollars per share)				$ 1,000
Annual rate percentage				8%
Divided closing price (in Dollars)				$ (500)
Preferred stock, shares issued					25
Preferred stock, shares outstanding					25
Series I Preferred Stock [Member]
Capital Stock [Line Items]
Designated preferred stock issued			4,000
Annual rate percentage			8%
Preferred stock, shares issued					25
Preferred stock, shares outstanding					25
Preferred stock, description					the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I is not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company has the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series I between May 2, 2021 and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense.
Liquidation preference value (in Dollars)			$ 1,000
Aggregate redemption price (in Dollars)	$ 25,000
Series I Preferred Stock [Member]
Capital Stock [Line Items]
Aggregate of value (in Dollars)		$ 25,000

Capital Stock (Details) - Par_3

Capital Stock (Details) - Part-3 - USD ($)						3 Months Ended
	Apr. 22, 2022	Jul. 01, 2020	Apr. 27, 2020	Jun. 03, 2019	Apr. 03, 2019	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Capital Stock [Line Items]
Aggregate of shares						172,730
Shares issued								18,645,028
Annualized dividends						4%
Preferred stock per share (in Dollars per share)						$ 0.0001	$ 0.0001
Series J Preferred Stock [Member]
Capital Stock [Line Items]
Designated preferred stock issued					100,000
Preferred stock per share (in Dollars per share)					$ 1,000
Preferred stock issued and outstanding					210
Series K Preferred Stock [Member]
Capital Stock [Line Items]
Designated preferred stock issued				4,000
Preferred stock per share (in Dollars per share)				$ 1,000
Dividend rate, percentage				8%
Aggregate of shares						10
Shares issued						10
Preferred stock, shares issued						297
Preferred stock, shares outstanding						297
Aggregate redemption price (in Dollars)	$ 297,150
Series L Preferred Stock [Member]
Capital Stock [Line Items]
Designated preferred stock issued				100,000
Preferred stock per share (in Dollars per share)				$ 1,000
Preferred stock issued and outstanding						321
Series M Preferred Stock [Member]
Capital Stock [Line Items]
Designated preferred stock issued		800,000
Dividend rate, percentage		10%
Preferred stock, shares issued						40,300
Preferred stock, shares outstanding						40,300
Stated value (in Dollars)		$ 25
Liquidation preference value (in Dollars)		$ 25
Redemption price, per share (in Dollars per share)		$ 37.5
Stated value percentage		150%
Series O Preferred Stock [Member]
Capital Stock [Line Items]
Designated preferred stock issued			2,000
Preferred stock per share (in Dollars per share)			$ 1,000
Preferred stock issued and outstanding						190
Percentage of conversion price			200%
Series P Preferred Stock [Member]
Capital Stock [Line Items]
Designated preferred stock issued			500
Preferred stock issued and outstanding						30
Preferred stock per share (in Dollars per share)			$ 1,000
Percentage of common stock			4.99%
Increased common stock percentage			9.99%
Maximum [Member] | Series O Preferred Stock [Member]
Capital Stock [Line Items]
Annual rate percentage			8%
Outstanding common stock percentage			9.99%
Minimum [Member] | Series O Preferred Stock [Member]
Capital Stock [Line Items]
Annual rate percentage			4%
Outstanding common stock percentage			4.99%

Capital Stock (Details) - Par_4

Capital Stock (Details) - Part-4 - $ / shares			3 Months Ended
	Nov. 16, 2020	Aug. 21, 2020	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Capital Stock [Line Items]
Preferred stock per share (in Dollars per share)			$ 0.0001	$ 0.0001
Shares issued					18,645,028
Aggregate preferred stock, share issued			135
Series Q Preferred Stock [Member]
Capital Stock [Line Items]
Designated preferred stock issued		2,000
Preferred stock per share (in Dollars per share)		$ 1,000
Dividend rate, percentage		12%
Percentage of common stock		200%
Percentage of common stock outstanding		4.99%
Common stock outstanding increased percentage		9.99%
Shares issued			4,576,458
Conversion of Stock, Shares Issued			20
Preferred stock, shares issued			410
Preferred stock, shares outstanding			410
Series R Preferred Stock [Member]
Capital Stock [Line Items]
Designated preferred stock issued	5,000
Preferred stock per share (in Dollars per share)	$ 1,000
Dividend rate, percentage	10%
Percentage of common stock	200%
Percentage of common stock outstanding	4.99%
Common stock outstanding increased percentage	9.99%
Shares issued			1,473
Series R Preferred Stock [Member]
Capital Stock [Line Items]
Shares issued			30,496,772

Capital Stock (Details) - Par_5

Capital Stock (Details) - Part-5 - USD ($)

3 Months Ended

12 Months Ended

Feb. 18, 2022

Feb. 11, 2022

Dec. 06, 2021

Dec. 01, 2021

May 26, 2021

Apr. 28, 2021

Mar. 01, 2021

Feb. 05, 2021

Nov. 16, 2020

Aug. 21, 2020

Apr. 27, 2020

Mar. 31, 2024

Mar. 31, 2023

Dec. 31, 2023

Apr. 22, 2022

Capital Stock [Line Items]

Shares issued

18,645,028

Aggregate preferred stock, share issued

135

Preferred stock per share (in Dollars per share)

$ 0.0001

$ 0.0001

Common stock par value (in Dollars per share)

$ 0.0001

$ 0.01

$ 0.0001

Outstanding common stock

4.99%

Conversion prices (in Dollars per share)

$ 9.99

$ 0.00816

Aggregate of shares

172,730

Converted shares

25

Gain on shares aggregate (in Dollars)

$ 687,678

$ 1,802,443

Description of share prices ranging

The Company issued 20,698,356 shares of common stock for services at fair value of $213,081, at share prices ranging from $0.0065 - $0.011.

Shares of common stock

20,937,829

Fair value (in Dollars)

$ 169,596

Conversion of common shares

101,048,108

150,448,490

Conversion of preferred shares (in Dollars)

$ 455,000

$ 875,000

Aggregate stock redeemed

182,145,203

Common stock amount (in Dollars)

$ 1,802,443

Equity financing purchase agreement (in Dollars)

$ 130,584

Conversion price decrease (in Dollars per share)

$ 0.0064

Fair value conversion agreements (in Dollars)

$ 8,584

Percentage of issued and outstanding

90.83%

WODI [Member]

Capital Stock [Line Items]

Non-controlling interest

9.17%

Minimum [Member]

Capital Stock [Line Items]

Prices ranging (in Dollars per share)

$ 0.0135

Price per share (in Dollars per share)

$ 0.0065

Maximum [Member]

Capital Stock [Line Items]

Prices ranging (in Dollars per share)

$ 0.0051

Price per share (in Dollars per share)

0.011

Water On Demand, Inc. (‘WODI’) Preferred Stock [Member]

Capital Stock [Line Items]

Designated preferred stock issued

50,000,000

Preferred stock per share (in Dollars per share)

$ 0.0001

WODI [Member] | Minimum [Member]

Capital Stock [Line Items]

Prices ranging (in Dollars per share)

83,352,197

WODI [Member] | Maximum [Member]

Capital Stock [Line Items]

Prices ranging (in Dollars per share)

$ 0.01

Financing Agreement [Member]

Capital Stock [Line Items]

Shares of common stock

20,698,356

Principal amount (in Dollars)

$ 213,081

Services [Member]

Capital Stock [Line Items]

Shares of common stock

23,716,123

Fair value (in Dollars)

$ 253,210

Series S Preferred Stock [Member]

Capital Stock [Line Items]

Designated preferred stock issued

430

Preferred stock per share (in Dollars per share)

$ 1,000

Dividend rate, percentage

12%

Percentage of common stock

200%

Percentage of common stock outstanding

4.99%

Increased common stock percentage

9.99%

Shares issued

2,272,728

Aggregate preferred stock, share issued

10

Preferred stock, shares issued

110

Preferred stock, shares outstanding

110

Series U preferred stock [Member]

Capital Stock [Line Items]

Designated preferred stock issued

5,000

Percentage of common stock

150%

Percentage of common stock outstanding

4.99%

Preferred stock, shares outstanding

270

Preferred stock per share (in Dollars per share)

$ 1,000

Common stock outstanding increased percentage

9.99%

Common stock par value (in Dollars per share)

$ 0.2

Conversion price percentage

200%

Warrants shares (in Dollars)

$ 53,033,816

Series U preferred stock [Member] | Minimum [Member]

Capital Stock [Line Items]

Exercise price (in Dollars per share)

$ 0.13

Series U preferred stock [Member] | Maximum [Member]

Capital Stock [Line Items]

Exercise price (in Dollars per share)

$ 0.25

Series U preferred stock [Member] | Preferred Stock [Member]

Capital Stock [Line Items]

Fair value of warrants (in Dollars)

$ 360,185

Series Y Preferred Stock [Member]

Capital Stock [Line Items]

Designated preferred stock issued

3,000

Aggregate preferred stock, share issued

2.4

Preferred stock, shares issued

24.7

Preferred stock, shares outstanding

24.7

Warrants shares (in Dollars)

$ 1,561,500

Original issue price (in Dollars per share)

$ 100,000

Annual net profits percentage

25%

Subsidiary’s annual net profits percentage

25%

Amount of accrued dividends (in Dollars)

$ 543,664

Series Y Preferred Stock [Member] | Minimum [Member]

Capital Stock [Line Items]

Exercise prices per share (in Dollars per share)

$ 1

Series W Preferred Stock [Member]

Capital Stock [Line Items]

Designated preferred stock issued

3,390

Aggregate preferred stock, share issued

50

Preferred stock, shares issued

847

Preferred stock, shares outstanding

847

Preferred stock per share (in Dollars per share)

$ 1,000

Annual rate percentage

12%

Stated value percentage

200%

Outstanding common stock percentage

4.99%

Series R Preferred Stock [Member]

Capital Stock [Line Items]

Designated preferred stock issued

5,000

Dividend rate, percentage

10%

Percentage of common stock

200%

Percentage of common stock outstanding

4.99%

Shares issued

1,473

Preferred stock per share (in Dollars per share)

$ 1,000

Common stock outstanding increased percentage

9.99%

Aggregate of shares

3

Series Q Preferred Stock [Member]

Capital Stock [Line Items]

Designated preferred stock issued

2,000

Dividend rate, percentage

12%

Percentage of common stock

200%

Percentage of common stock outstanding

4.99%

Shares issued

4,576,458

Preferred stock, shares issued

410

Preferred stock, shares outstanding

410

Preferred stock per share (in Dollars per share)

$ 1,000

Common stock outstanding increased percentage

9.99%

Aggregate shares

252,500

Conversion shares

52,047,138

Series Z Preferred Stock [Member]

Capital Stock [Line Items]

Designated preferred stock issued

25

Exercise prices per share (in Dollars per share)

$ 0.1

Original issue price (in Dollars per share)

$ 10,000

Fair value of warrants (in Dollars)

$ 16,183

Number of warrants shares

2,500,000

2,500,000

Series V Preferred Stock [Member]

Capital Stock [Line Items]

Percentage of common stock outstanding

4.99%

Increased common stock percentage

9.99%

Series T Preferred Stock [Member]

Capital Stock [Line Items]

Designated preferred stock issued

25

Aggregate preferred stock, share issued

630

Number of warrants shares

25,200,000

Series B Preferred Stock [Member] | OriginClear, Inc Preferred Stock [Member]

Capital Stock [Line Items]

Preferred stock, shares outstanding

0

Series O Preferred Stock [Member]

Capital Stock [Line Items]

Designated preferred stock issued

2,000

Preferred stock per share (in Dollars per share)

$ 1,000

Shares of common stock

172,730

238,003

Series O Preferred Stock [Member] | Minimum [Member]

Capital Stock [Line Items]

Annual rate percentage

4%

Outstanding common stock percentage

4.99%

Series O Preferred Stock [Member] | Maximum [Member]

Capital Stock [Line Items]

Annual rate percentage

8%

Outstanding common stock percentage

9.99%

Common Stock [Member]

Capital Stock [Line Items]

Shares issued

85,836,889

Common stock par value (in Dollars per share)

$ 0.05

$ 0.01

Aggregate stock redeemed

83,352,197

Common stock amount (in Dollars)

$ 687,678

Common Stock [Member] | WODI [Member]

Capital Stock [Line Items]

Shares issued

15,550,000

Common Stock [Member]

Capital Stock [Line Items]

Shares issued

11,655,012

Capital Stock (Details) - Sched

Capital Stock (Details) - Schedule of Non-controlling Interest - WODI Ownership Percentage [Member]	Dec. 31, 2023
Redeemable Noncontrolling Interest [Line Items]
Total ownership percentage	100%
OriginClear, Inc. [Member]
Redeemable Noncontrolling Interest [Line Items]
Total ownership percentage	90.83%
Prior Reg A Holders [Member]
Redeemable Noncontrolling Interest [Line Items]
Total ownership percentage	0.19%
Prior Series A Holders [Member]
Redeemable Noncontrolling Interest [Line Items]
Total ownership percentage	3.87%
Prior Series B Holders [Member]
Redeemable Noncontrolling Interest [Line Items]
Total ownership percentage	5.11%

Restricted Stock Grants and W_3

Restricted Stock Grants and Warrants (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Options and Warrants [Line Items]
Board of directors amendment, description	May 12, 2016, and August 4, 2022, the Company entered into Restricted Stock Grant Agreements (“the RSGAs”) with its Chief Executive Officer, the Board, Employees and Consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price.
Gross revenue	$ 6,573	$ 6,573
Aggregate shares issued (in Shares)	20,937,829
Stock-based compensation	$ 169,596	$ 92,724
Warrants issued (in Shares)		18,645,028
Proceeds of warrants	426,230
Chief Executive Officer [Member]
Options and Warrants [Line Items]
Gross revenue	15,000,000
Accepted accounting principles	$ 1,500,000
Warrant [Member]
Options and Warrants [Line Items]
Warrants issued (in Shares)	1,427,049
Purchase of warrants (in Shares)	2,020,000
Derivative liability	$ 457,304
Warrants outstanding	$ 0

Restricted Stock Grants and W_4

Restricted Stock Grants and Warrants (Details) - Schedule of Warrant Activity	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Number of Warrants [Member]
Schedule of Warrant Activity [Line Items]
Number of Warrants, Outstanding - beginning of period | shares	64,401,089
Number of Warrants, Granted | shares	2,020,000
Number of Warrants, Exercised | shares
Number of Warrants, Expired | shares
Number of Warrants, Outstanding - end of period | shares	66,421,089
Weighted average exercise price [Member]
Schedule of Warrant Activity [Line Items]
Weighted average exercise price, Outstanding - beginning of period | $ / shares	$ 0.1383
Weighted average exercise price, Granted | $ / shares	0.125
Weighted average exercise price, Exercised | $ / shares
Weighted average exercise price, Expired | $ / shares
Weighted average exercise price, Outstanding - end of period | $ / shares	$ 0.1379

Restricted Stock Grants and W_5

Restricted Stock Grants and Warrants (Details) - Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Class of Warrant or Right [Line Items]
Warrants Outstanding	66,421,089
Warrants Exercisable	66,421,089
0.02 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.02
Warrants Outstanding	600,000
Warrants Exercisable	600,000
Weighted Average Remaining Contractual Life (years)	2 years 5 months 1 day
0.0275 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.0275
Warrants Outstanding	8,727,273
Warrants Exercisable	8,727,273
Weighted Average Remaining Contractual Life (years)	7 years 1 month 28 days
0.10 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.1
Warrants Outstanding	2,500,000
Warrants Exercisable	2,500,000
Weighted Average Remaining Contractual Life (years)	2 years 10 months 20 days
0.125 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.125
Warrants Outstanding	49,273,816
Warrants Exercisable	49,273,816
0.125 [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 9 months 3 days
0.125 [Member] | Maximum [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	5 years
0.25 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.25
Warrants Outstanding	3,760,000
Warrants Exercisable	3,760,000
0.25 [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 8 months 19 days
0.25 [Member] | Maximum [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 9 months
1.00 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 1
Warrants Outstanding	1,560,000
Warrants Exercisable	1,561,500
1.00 [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	3 months
1.00 [Member] | Maximum [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	8 months 15 days

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Jan. 25, 2021	Nov. 19, 2020
Convertible Promissory Notes [Line Items]
Aggregate remaining balance	$ 683,700
Convertible promissory notes	18,381,089
Aggregate balance	1,200,000
Convertible debt received funds	4,619,985
Conversion price per share (in Dollars per share)		$ 0.0064
Derivative liability	$ 20,052,649
Aggregate of share (in Shares)	172,730
Original Issue Discount Notes [Member]
Convertible Promissory Notes [Line Items]
Common stock conversion	$ 30,620
Trade price percentage	50%
Aggregate remaining amount	$ 184,124
Accrued interest	$ 13,334
Maturity date	Jun. 30, 2028
Convertible promissory notes	$ 5,600
Short term remaining balance	62,275
Minimum [Member]
Convertible Promissory Notes [Line Items]
Conversion of stock	4,200
Maximum [Member]
Convertible Promissory Notes [Line Items]
Common stock conversion	$ 9,800
2014-2015 Notes [Member]
Convertible Promissory Notes [Line Items]
Interest rate	10%
Trade price percentage	50%
Unsecured Convertible Promissory Note [Member]
Convertible Promissory Notes [Line Items]
Interest rate	10%
Trade price percentage	50%
Convertible debt	$ 960,000
Interest per annum	10%
Unsecured Convertible Promissory Note [Member] | Minimum [Member]
Convertible Promissory Notes [Line Items]
Common stock conversion	$ 1,400
Unsecured Convertible Promissory Note [Member] | Maximum [Member]
Convertible Promissory Notes [Line Items]
Common stock conversion	$ 5,600
Dec 2015 Note [Member]
Convertible Promissory Notes [Line Items]
Interest rate	0%
Dec 2015 Note [Member] | Short-Term Debt [Member]
Convertible Promissory Notes [Line Items]
Aggregate remaining amount	$ 167,048
Dec 2015 Note [Member] | Convertible Debt [Member]
Convertible Promissory Notes [Line Items]
Accounts payable	$ 432,048
Percentage of average of lowest sale prices	75%
Sep 2016 Note [Member] | Short-Term Debt [Member]
Convertible Promissory Notes [Line Items]
Aggregate remaining amount	$ 430,897
Sep 2016 Note [Member] | Convertible Debt [Member]
Convertible Promissory Notes [Line Items]
Interest rate	0%
Accounts payable	$ 430,896
Percentage of average of lowest sale prices	75%
Nov 20 Note [Member]
Convertible Promissory Notes [Line Items]
Interest rate	10%
Trade price percentage	50%
Convertible debt received funds	$ 50,000
Conversion price per share (in Dollars per share)	$ 0.05
Penalty per day	$ 2,000
Nov 20 Note [Member] | Long-Term Debt [Member]
Convertible Promissory Notes [Line Items]
Aggregate remaining amount	$ 13,772
Nov 20 Note [Member] | Unsecured Convertible Promissory Note [Member]
Convertible Promissory Notes [Line Items]
Convertible debt				$ 50,000
Jan 21 Note [Member]
Convertible Promissory Notes [Line Items]
Interest rate	10%
Trade price percentage	50%
Maturity date	Jan. 25, 2022
Conversion price per share (in Dollars per share)	$ 0.05
Penalty per day	$ 2,000
Jan 21 Note [Member] | Unsecured Convertible Promissory Note [Member]
Convertible Promissory Notes [Line Items]
Convertible debt			$ 60,000
Convertible debt received funds	60,000
Remaining debt amount	$ 60,000
Common Stock [Member]
Convertible Promissory Notes [Line Items]
Aggregate of share (in Shares)	83,352,197
Aggregate amount	$ 692,000

Convertible Promissory Notes _2

Convertible Promissory Notes (Details) - Schedule of Outstanding Convertible Promissory Notes - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Schedule of Outstanding Convertible Promissory Notes [Abstract]
Convertible Promissory Notes	$ 2,617,692
Less current portion	597,945
Total long-term liabilities	$ 2,019,747	$ 144,747

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Revenue from Contracts with Customers [Abstract]
Revenue of continued operations	$ 6,573	$ 6,573
Revenue of discontinued operations	936,864	$ 1,999,821
Contract asset	353,311		$ 445,102
Contract liability	$ 1,798,364		$ 1,346,366

Revenue from Contracts with C_4

Revenue from Contracts with Customers (Details) - Schedule of Good or Service from Contracts with Customers - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule of Good or Service from Contracts with Customers [Abstract]
Equipment Contracts	$ 363,358	$ 926,190
Component Sales	206,387	198,391
Waste Water Treatment Systems		791,075
Pump Stations	296,360	75,615
Rental Income	6,573	6,573
Services Sales	70,534	8,550
Commission & Training	225
Total	$ 943,437	$ 2,006,394

Financial Assets (Details)

Financial Assets (Details) - USD ($)			3 Months Ended
	Nov. 12, 2021	May 15, 2018	Mar. 31, 2024
Financial Assets [Line Items]
Shares received (in Shares)			135
Share price amount		$ 30,000
Preferred shares fair value			$ 3,200
Fair value loss			0
Investment in securities in fair value amount			63,292
Unrealized gain			$ 27,125
OriginClear, Inc.Technology [Member]
Financial Assets [Line Items]
Fair value market price per share (in Dollars per share)		$ 0.0075
Series C Convertible Preferred Stock [Member]
Financial Assets [Line Items]
Shares received (in Shares)		4,000
WTII common stock [Member]
Financial Assets [Line Items]
Aggregate share issued (in Shares)	45,208,649
WTII common stock [Member] | Series C Convertible Preferred Stock [Member]
Financial Assets [Line Items]
Shares received (in Shares)		1,000,000

Loans Payable (Details)

Loans Payable (Details) - USD ($)			3 Months Ended
	Dec. 06, 2023	Jun. 12, 2020	Mar. 31, 2024
Loans Payable [Line Items]
Assets amount	$ 149,900		$ 1,749,970
Finance cost	59,900		624,810
Net balance			30,646
Net amount	$ 90,000
Loan			0
Remaining balance			$ 146,557
Economic Injury Disaster Loan [Member]
Loans Payable [Line Items]
Grant loan amount		$ 150,000

Water on Demand Inc. (_WODI_) (

Water on Demand Inc. (‘WODI’) (Details) - USD ($)

3 Months Ended

12 Months Ended

Oct. 25, 2023

Apr. 10, 2023

Dec. 22, 2022

Nov. 16, 2022

Mar. 31, 2024

Mar. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Sep. 21, 2023

Apr. 14, 2023

Feb. 07, 2023

Nov. 04, 2022

Water on Demand Inc. (‘WODI’) [Line Items]

Aggregate shares

172,730

Common stock, shares Issued

1,478,617,331

1,399,782,046

Common stock, shares outstanding

1,478,617,331

1,399,782,046

Paid total amount (in Dollars)

$ 1,137,267

Membership interest amount (in Dollars)

$ 400,000

Compensating amount (in Dollars)

$ 737,267

Notes payable to related party (in Dollars)

$ 737,267

Interest rate per annum

10%

Deposit amount (in Dollars)

$ 977,500

Public share price (in Dollars per share)

$ 0.1

Special Meeting total

10,514,410

Special Meeting total number of percentage

81.61%

Sufficient votes Percentage

65%

Other assets exchange shares

6,000,000

Shares issued

18,645,028

Total shares

5,687,847

Issued and outstanding percentage

84.59%

Additional term

1 year

Aggregate amount (in Dollars)

$ 4,619,985

Unsecured promissory notes (in Dollars)

4,619,985

Paid amount (in Dollars)

590,000

Purchase of class B founder shares at lower of cost (in Dollars)

$ 400,000

Stock price

50,000

Restricted shares percentage

25%

Issuance of shares

15,550,000

WODI [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Investments amount (in Dollars)

$ 1,000

Aggregate shares

12,000

Total proceeds (in Dollars)

$ 60,000

Common stock, shares Issued

10,000,000

Common stock, shares outstanding

10,000,000

Restricted shares percentage

25%

Common stock outstanding percentage

1%

Sponsor [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Membership interest, percentage

100%

Sponsor own shares

2,343,750

SPAC [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Purchase price (in Dollars)

$ 400,000

OCLN [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Shares issued

2,171,068

Progressive Water Treatment Restricted Stock Grant Agreements [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Shares issued

2,581,344

Issuance of shares

3,069,100

SPAC [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Merger percentage

75%

Progressive Water Treatment Restricted Stock Grant Agreements [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Conversion price per share (in Dollars per share)

$ 0.19737

Share-Based Payment Arrangement, Tranche One [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Vested shares percentage

6.25%

Share-Based Payment Arrangement, Tranche Two [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Vested shares percentage

6.25%

Class B Common Stock [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Common stock, shares Issued

2,443,750

Common stock, shares outstanding

2,443,750

Common Stock [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Shares issued

85,836,889

Common Stock [Member] | WODI [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Shares issued

15,550,000

Common Stock [Member]

Water on Demand Inc. (‘WODI’) [Line Items]

Aggregate shares

83,352,197

Special Meeting total

4,208,756

Common stock outstanding percentage

1%

Line of Credit (Details)

Line of Credit (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Line of Credit [Abstract]
Line of aggregate amount		$ 345,875
Interest rate, percentage		26.07%
Paid principal amount	$ 256,107
Leaving principal balance	$ 89,768

Assets Held for Sale _ Contin_2

Assets Held for Sale – Continuing Operations (Details) - USD ($)				3 Months Ended	12 Months Ended
	Jun. 21, 2023	Apr. 08, 2023	Mar. 01, 2021	Mar. 31, 2024	Dec. 31, 2022	Dec. 31, 2021
Assets Held For Sale [Abstract]
Aggregate shares (in Shares)			630
Common stock valued , per share (in Dollars per share)			$ 0.05
Impairment					$ 114,000	$ 116,000
Offer price					400,000
Property plant And equipment					114,000
Sale of the property		$ 400,000
Initial payment		235,000
Remaining initial payment		165,000
Installments		$ 11,000
Payment received	$ 164,935
Closing fees	65,493
Receivable	169,572
Additional payments total				$ 103,572
Receivable amount	$ 169,572			$ 66,000
Maximum [Member]
Assets Held For Sale [Abstract]
Asset for sale					514,000	630,000
Minimum [Member]
Assets Held For Sale [Abstract]
Asset for sale					$ 400,000	$ 514,000
Series T Preferred Stock [Member]
Assets Held For Sale [Abstract]
Aggregate shares (in Shares)			630	630
Warrants shares (in Shares)			25,200,000
Fair value of the property			$ 630,000
Property, Plant and Equipment [Member] | Series T Preferred Stock [Member]
Assets Held For Sale [Abstract]
Long term asset				$ 630,000

Commitments and Contingencies (

Commitments and Contingencies (Details)	Mar. 31, 2024 USD ($) m²
Commitments and Contingencies [Line Items]
Monthly rent	$ 8,500
Warrant reserve	$ 20,000
Mckinney [Member]
Commitments and Contingencies [Line Items]
Area of land (in Square Meters) | m²	12,000

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)										3 Months Ended
	May 14, 2024	May 06, 2024	May 01, 2024	Apr. 24, 2024	Apr. 12, 2024	Apr. 09, 2024	Apr. 05, 2024	Apr. 03, 2024	Apr. 01, 2024	Mar. 31, 2024	Mar. 31, 2023
Subsequent Events [Line Items]
Shares redeemed											182,145,203
Subsequent Event [Member]
Subsequent Events [Line Items]
Aggregate amount (in Dollars)		$ 255,000					$ 255,000
Common Stock [Member]
Subsequent Events [Line Items]
Shares redeemed										83,352,197
Common Stock [Member] | Subsequent Event [Member]
Subsequent Events [Line Items]
Aggregate of shares issued									2,969,808
Series Y Preferred Stock [Member]
Subsequent Events [Line Items]
Converted aggregate per share (in Dollars per share)						$ 1.3
Series Y Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events [Line Items]
Aggregate of shares issued					1,050,400	1,050,400
Converted aggregate per share (in Dollars per share)			$ 1.3		$ 1.3			$ 1.3
Aggregate shares of common stock			18,560,607					18,560,607
Aggregate purchase price (in Dollars)					$ 131,300	$ 131,300
Series O Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events [Line Items]
Converted aggregate per share (in Dollars per share)	$ 5
Aggregate shares of common stock	965,252
Common Stock [Member] | Subsequent Event [Member]
Subsequent Events [Line Items]
Aggregate of shares issued			2,969,808	102,883,285				102,883,285
Shares redeemed			42,975,239					42,975,239